The Recognition and Management of Early Psychosis

A Preventive Approach

The Recognition and Management of Early Psychosis

Psychotic illness is managed and treated with best results when it is recognized at the earliest stages of a person developing the disorder, or when that person is identified as being at high risk of doing so. Describing a stage-specific model highlighting the risk, the clinical and biological factors present during the development of the illness, and the best treatments available for each of these stages, this new edition will guide practitioners and researchers in the adoption of carefully planned management strategies fully integrating treatment with prevention. Issues such as resistance to drugs and vocational recovery are covered, with related topics such as service organization and community education. This will be essential reading for all those involved in the care of people with early psychotic illness, or those responsible for the organization of services.


 Reviews:

"This is a superb book, and every clinician who encounters patients at risk for psychosis or suffering from first episode psychosis should be familiar with the material it presents."
--Doody's Review Service

'The Recognition and Management of Early Psychosis: A Preventive Approach (Second Edition) presents the field of early detection and early intervention in an interesting and informative format. … It is undoubtedly a comprehensive source of information with many references to guide further reading and may also be a useful teaching tool for college and university courses on this topic. … This book is a clear and approachable presentation of early detection and early intervention, and I recommend it strongly.' The Journal of Psychological Medicine

Östman, M. & Hansson, L. (2004). Appraisal of caregiving, burden and psychological distress in relatives of psychiatric inpatients. European Psychiatry, 19, 402–7.
Abi-Dargham, A., Rodenhiser, R. J., Printz, D. et al. (2000). Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proceedings of the National Academy of Sciences USA, 97, 8104–9.
Adams, K. B. & Sanders, S. (2004). Alzheimer's caregiver differences in experience of loss, grief reactions and depressive symptoms across stage of disease: a mixed-method analysis. Dementia: International Journal of Social Research and Practice, 3, 195–210.
Addington, A. M., Gornick, M., Duckworth, J. et al. (2005). GAD1 (2q31.1), which encodes glutamic acid decarboxylase (GAD(67)), is associated with childhood-onset schizophrenia and cortical gray matter volume loss. Molecular Psychiatry, 10, 581–8.
Addington, D., Addington, J. & Patten, S. (1998). Depression in people with first-episode schizophrenia. British Journal of Psychiatry, 172(Suppl 33), s90–2.
Addington, D., McKenzie, E., Addington, J. et al. (2005a). Performance measures for early psychosis treatment services. Psychiatric Services, 56, 1570–82.
Addington, J. & Addington, D. (2001). Impact of an early psychosis programme on substance use. Psychiatric Rehabilitation Journal, 25, 60–7.
Addington, J. & Addington, D. (2001a). Early intervention for psychosis: the Calgary Early Psychosis Treatment and Prevention Program. Canadian Psychiatric Association Bulletin, 33, 11–13.
Addington, J. & Addington, D. (2001b). Impact of an early psychosis program on substance abuse. Psychiatric Rehabilitation Journal, 25, 60–7.
Addington, J. & Addington, D. (2005). Clinical trials during the prodromal stage of schizophrenia. [Letter to the editor.] American Journal of Psychiatry, 162, 1387.
Addington, J. & Addington, D. (2006). Phase specific group treatment in an early psychosis program. In J. O. Johannessen, B. Martindale & J. Cullberg (eds.), Evolving Psychosis: Different Stages Different Treatments. London: Brunner-Routledge, pp. 124–38.
Addington, J. & Burnett, P. (2004). Working with families in the early stages of psychosis. In J. F. M. Gleeson & P. D. McGorry (eds.), Psychological Interventions for Early Psychosis. Chichester, UK: John Wiley, pp. 99–116.
Addington, J. & Burnett, P. (2004). Working with families in the early stages of psychosis. In J. F. M. Gleeson & P. D. McGorry (eds.), Psychological Interventions for Early Psychosis. Chichester, UK: John Wiley, pp. 99–116.
Addington, J. & Burnett, P. (2004). Working with families in the early stages of psychosis. In J. F. M. Gleeson & P. D. McGorry (eds.), Psychological Interventions in Early Psychosis. Chichester, UK: John Wiley, pp. 99–116.
Addington, J. & Gleeson, J. (2005). Implementing cognitive behaviour therapy for first episode psychosis, British Journal of Psychiatry, 187(Suppl 48), s272–6.
Addington, J. (2003). An integrated treatment approach to substance abuse in an early psychosis program. In H. Graham, K. Mueser, M. Birchwood & A. Copello (eds.), Substance Misuse in Psychosis: Approaches to Treatment and Service Delivery. Chichester, UK: John Wiley, pp. 121–35.
Addington, J., Brooks, B. & Addington, D. (2003c). Cognitive functioning in first episode psychosis: initial presentation. Schizophrenia Research, 62, 59–64.
Addington, J., Chaves, A. C. & Addington, D. (2006). Diagnostic stability over one year in first episode psychosis. Schizophrenia Research, 86, 71–5.
Addington, J., Coldham, E. L., Jones, B., Ko, T. & Addington, D. (2003). The first episode of psychosis: the experience of relatives. Acta Psychiatrica Scandinavica, 108, 285–9.
Addington, J., Coldham, E. L., Jones, B., Ko, T. & Addington, D. (2003b). The first episode of psychosis: the experience of relatives. Acta Psychiatrica Scandinavica, 108, 285–9.
Addington, J., Collins, A., McCleery, A. & Addington, D. (2005). The role of family work in early psychosis. Schizophrenia Research, 79, 77–83.
Addington, J., Collins, A., McCleery, A. & Addington, D. (2005a). The role of family work in early psychosis. Schizophrenia Research, 79, 77–83.
Addington, J., Francey, S. M. & Morrison, A. P. (2006). Working With People at High Risk of Developing Psychosis: A Treatment Handbook. Chichester, UK: John Wiley.
Addington, J., Leriger, E. & Addington, D. (2003a). Symptom outcome 1 year after admission to an early psychosis program. Canadian Journal of Psychiatry, 48, 204–7.
Addington, J., Leriger, E. & Addington, D. (2003a). Symptom outcome one year after admission to an early psychosis program. Canadian Journal of Psychiatry, 48, 204–7.
Addington, J., McCleery, A. & Addington, D. (2005b). Three year outcome of family work in an early psychosis program. Schizophrenia Research, 79, 107–16.
Addington, J., McCleery, A. & Addington, D. (2005b). Three-year outcome of family work in an early psychosis program. Schizophrenia Research, 79, 77–83.
Addington, J., Saeedi, H. & Addington, D. (2005c). The course of cognitive functioning in first episode psychosis: changes over time and impact on outcome. Schizophrenia Research, 78, 35–43.
Addington, J., van Mastrigt, S. & Addington, D. (2004). Duration of untreated psychosis: impact on 2-year outcome. Psychological Medicine, 34, 277–84.
Addington, J., van Mastrigt, S., Hutchinson, J. & Addington, D. (2002). Pathways to care: help seeking behaviour in first episode psychosis. Acta Psychiatrica Scandinavica, 106, 358–64.
Addington, J., van Mastrigt, S., Hutchinson, J. & Addington, D. (2002). Pathways to care: help seeking behaviour in first episode psychosis. Acta Psychiatrica Scandinavica, 106, 358–64.
Addington, J., van Mastrigt, S., Hutchinson, J. & Addington, D. (2002). Pathways to care: help seeking behaviour in first-episode psychosis. Acta Psychiatrica Scandinavica, 106, 358–64.
Addington, J., Williams, J., Young, J. & Addington, D. (2004). Suicidal behaviour in early psychosis. Acta Psychiatrica Scandinavica, 109, 116–20.
Addington, J., Williams, J., Young, J. & Addington, D. (2004). Suicide behaviour in early psychosis. Acta Psychiatrica Scandinavica, 109, 116–20.
Addington, J., Young, J. & Addington, D. (2003). Social outcome in early psychosis. Psychological Medicine, 33, 1119–24.
Addington, J., Young, J. & Addington, D. (2003b). Social outcome in early psychosis. Psychological Medicine, 33, 1119–24.
Adlard, S. (1997). An Analysis of Health Damaging Behaviours in Young People at High Risk of Psychosis. Fellowship dissertation, Royal College and New Zealand College of Psychiatrists, Melbourne.
Agerbo, E., Byrne, M., Eaton, W. W. & Mortensen, P. B. (2003). Schizophrenia, marital status and employment: a forty year study. Schizophrenia Research, 60(Suppl 1), 32.
Agerbo, E., Byrne, M., Eaton, W. W. & Mortensen, P. B. (2004). Marital and labor market status in the long run in schizophrenia. Archives of General Psychiatry, 61, 28–33.
Akiskal, H. S. (1981). Subaffective disorders: dysthymic, cyclothymic and bipolar II disorders in the ‘borderline’ realm. Psychiatric Clinics of North America, 4, 25–46.
Akiskal, H. S. (1999). Bipolarity: beyond classic mania. Psychiatric Clinics of North America, 22, 512–703.
Akiskal, H. S., Downs, J., Jordan, P. et al. (1985). Affective disorders in referred children and younger siblings of manic depressives. Mode of onset and prospective course. Archives of General Psychiatry, 42, 996–1003.
Akiskal, H. S., Hantouche, E. G., Azorin, J. M. et al. (2003). Clinical characterization acute mania: data in 1090 patients – ‘EPIMAN-II’. Bipolar Disorders, 5(Suppl 1), 27.
Albiston, D. J., Francey, S. M. & Harrigan, S. M. (1998). Group programmes for recovery from early psychosis. British Journal of Psychiatry, 172(Suppl 33), s117–21.
Albiston, D., Francey, S. M. & Harrigan, S. M. (1998). Group programs for recovery from early psychosis. British Journal of Psychiatry, 172(Suppl 33), s117–21.
Allen, M. H., Currier, G. W., Hughes, D. H., Reyes-Harde, M. & Docherty, J. P. (2001). The Expert Consensus Guideline Series. Treatment of behavioral emergencies. Postgraduate Medicine, 1–88.
Allin, M. & Murray, R. M. (2002). Schizophrenia: a neurodevelopmental or neurodegenerative disorder? Current Opinion in Psychiatry, 15, 9–15.
Allison, D. B., Mentore, J. L., Heo, M. et al. (1999). Antipsychotic-induced weight gain: a comprehensive research synthesis. American Journal of Psychiatry, 156, 1686–96.
Almond, S., Knapp, M., Francois, C., Toumi, M. & Brugha, T. (2004). Relapse in schizophrenia: costs, clinical outcomes and quality of life. British Journal of Psychiatry, 184, 346–51.
Altamura, C., Guercetti, G. & Percudani, M. (1989). Dexamethasone suppression test in positive and negative schizophrenia. Psychiatry Research, 30, 69–75.
Amaddeo, F., Zambello, F., Tansella, M. & Thornicroft, G. (2001). Accessibility and pathways to psychiatric care in a community-based mental health system. Social Psychiatry and Psychiatric Epidemiology, 36, 500–7.
Amador, X. F., Freidman, J. H., Kasapis, C. et al. (1996). Suicidal behaviour in schizophrenia and its relationship to awareness of illness. American Journal of Psychiatry, 153, 1185–8.
Amador, X. F., Strauss, D. H., Yale, S. A. & Gorman, J. M. (1991). Awareness of illness in schizophrenia. Schizophrenia Bulletin, 17, 113–32.
Amminger, G. P., Harris, M. G., Conus, P. et al. (2006). Treated incidence of first-episode psychosis in the catchment area of EPPIC between 1997 and 2000. Acta Psychiatrica Scandinavica, 114, 337–45.
Anderson, C. M., Reiss, D. J. & Hogarty, G. E. (1986). Schizophrenia in the Family. A Practitioner's Guide to Psychoeducation and Management. New York: Guilford Press.
Andreasen, N. C. (1983). The Scale for the Assessment of Negative Symptoms (SANS). Iowa City: University of Iowa.
Andreasen, N. C. (1987). Creativity and mental illness: prevalence rates in writers and their first-degree relatives. American Journal of Psychiatry, 144, 1288–92.
Andreasen, N. C. (1987). The Comprehensive Assessment of Symptoms and History (CASH) Interview. Iowa City: University of Iowa.
Andreasen, N. C. (1997). Linking mind and brain in the study of mental illnesses: a project for a scientific psychopathology. Science, 275, 1586–93.
Andreasen, N. C. (2007). DSM and the death of phenomenology in America: an example of unintended consequences. Schizophrenia Bulletin, 33, 108–12.
Andreasen, N. C., Carpenter, W. T. Jr, Kane, J. M. et al. (2005). Remission in schizophrenia: proposed criteria and rationale for consensus. American Journal of Psychiatry, 162, 441–9.
Andreasen, N. C., Carpenter, W. T., Jr, Kane, J. M. et al. (2005). Remission in schizophrenia: proposed criteria and rationale for consensus. American Journal of Psychiatry, 162, 441–9.
Andreasen, N. C., Carpenter, W. T., Jr, Kane, J. M., et al. (2005). Remission in schizophrenia: proposed criteria and rationale for consensus. American Journal of Psychiatry, 162, 441–9.
Andreasson, S., Allebeck, P., Engstrom, A. & Rydberg, U. (1987). Cannabis and schizophrenia. A longitudinal study of Swedish conscripts. Lancet, ü, 1483–6.
Andrews, B. & Brown, G. W. (1995). Stability and change in low self-esteem: the role of psychosocial factors. Psychological Medicine, 25, 23–31.
Andriessen, K. (2006). On ‘intention’ in the definition of suicide. Suicide and Life-Threatening Behaviour, 36, 533–8.
Angermeyer, M. C. & Matschinger, H. (1999). Social representations of mental illness among the public. In J. Guimon, W. Fischer & N. Sartorius (eds.), The Image of Madness: The Public Facing Mental Illness and Psychiatric Treatment. Basel: Karger, pp. 20–8.
Angermeyer, M. C. & Matschinger, H. (2004). Public attitudes towards psychotropic drugs: have there been any changes in recent years? Pharmacopsychiatry, 37, 152–6.
Angermeyer, M. C. & Matschinger, H. (2005). Have there been any changes in the public's attitudes towards psychiatric treatment? Results from representative population surveys in Germany in the years 1990 and 2001. Acta Psychiatrica Scandinavica, 111, 68–73.
Angermeyer, M. C., Däumer, R. & Matschinger, H. (1993). Benefits and risks of psychotropic medication in the eyes of the general public: results of a survey in the Federal Republic of Germany. Pharmacopsychiatry, 26, 114–20.
Angst, J. (1985). Switch from depression to mania: a record study over decades between 1920 and 1982. Psychopathology, 18, 140–54.
Angst, J., Felder, W. & Lohmeyer, B. (1980). Course of schizoaffective psychoses: results of a followup study. Schizophrenia Bulletin, 6, 579–85.
Anonymous (1999). The wellspring of the clubhouse model for social and vocational adjustment of persons with serious mental illness. Psychiatric Services, 50, 1473–6.
Anthony, W. A. (2000). A recovery-oriented service system: setting some system level standards. Psychiatric Rehabilitation Journal, 24, 159–69.
APA (1980). Diagnostic and Statistical Manual of Mental Disorders, 3rd edn. Washington, DC: American Psychiatric Press.
APA (1987). Diagnostic and Statistical Manual of Mental Disorders 7, 3rd edn revised. Washington, DC: American Psychiatric Press.
APA (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC: American Psychiatric Press.
APA (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC: American Psychiatric Press.
APA (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC: American Psychiatric Press.
APA (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC: American Psychiatric Press.
APA (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC: American Psychiatric Press.
APA (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC: American Psychiatric Press.
APA (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC: American Psychiatric Press.
APA (2000). Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR (text revision), 4th edn [DSM-IV]. Washington, DC: American Psychiatric Press.
APA (2002). Practice guideline for the treatment of patients with bipolar disorder (revision). American Journal of Psychiatry, 159, 4–50.
APA (2004a). Practice Guidelines for the Treatment of Psychiatric Disorders, Compendium 2004, 2nd edn: Practice Guideline for the Treatment of Patients with Schizophrenia. Washington, DC: American Psychiatric Press, pp. 249–440.
APA (2004b). Practice Guidelines for the Treatment of Psychiatric Disorders, Compendium 2004, 2nd edn: Practice Guideline for the Treatment of Patients with Bipolar Disorder. Washington, DC: American Psychiatric Press, pp. 525–612.
APA (2004c). Practice Guidelines for the Treatment of Psychiatric Disorders, Compendium 2004, 2nd edn: Practice Guideline for the Treatment of Patients with Major Depressive Disorder. Washington, DC: American Psychiatric Press, pp. 440–524.
APA Steering Committee on Practice Guidelines (eds.) (2002). American Psychiatric Association Practice Guidelines for the Treatment of Psychiatric Disorders Compendium 2002. Washington, D.C: American Psychiatric Press.
APA. (1980). Diagnostic and Statistical Manual of Mental Disorders, 3rd edn. Washington, DC: American Psychiatric Press.
APA. (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC: American Psychiatric Press.
APA. (2004a). Practice guideline for the treatment of patients with schizophrenia (second edition). In American Psychiatric Association, Practice Guidelines for the Treatment of Psychiatric Disorders. Compendium 2004, Washington, DC: American Psychiatric Press, pp. 249–440.
APA. (2004b) Practice guideline for the treatment of patients with bipolar disorder (second edition). In American Psychiatric Association, Practice Guidelines for the Treatment of Psychiatric Disorders. Compendium 2004, Washington, DC: American Psychiatric Press, pp. 525–612.
APA. (2004c). Practice guideline for the treatment of patients with major depressive disorder (second edition). In American Psychiatric Association, Practice Guidelines for the Treatment of Psychiatric Disorders. Compendium 2004, Washington, DC: American Psychiatric Press, pp. 440–524.
Appleby, L., Shaw, J., Kapur, N. et al. (2006). Avoidable Deaths: Five Year Report into the National Confidential Inquiry into Suicide and Homicide by People with Mental Illness. London: The Stationary Office.
Appleby, L., Shaw, J., Sherratt, J. et al. (2001). Safety First: Five-year Report of the National Confidential Inquiry into Suicide and Homicide by People with Mental Illness. London: The Stationary Office.
Apter, A., Bleich, A., Plutchik, R., Mendelsohn, S. & Tyano, S. (1988). Suicidal behaviour, depression and conduct disorder in hospitalised adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 27, 696–9.
Aquilar, E. J., Haas, G., Manzanera, F. G. et al. (1997). Hopelessness and first-episode psychosis: a longitudinal study. Acta Psychiatrica Scandinavica, 96, 25–30.
Arduini, L., Kalyvoka, A., Stratta, P. et al. (2002). Subjective experiences in schizophrenia and bipolar disorders. European Archives of Psychiatry and Clinical Neuroscience, 252, 24–7.
Arendt, M., Rosenberg, R., Foldager, L., Perto, G. & Munk-Jorgensen, P. (2005). Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases. British Journal of Psychiatry, 187, 510–15.
Arendt, M., Rosenberg, R., Foldager, L., Perto, G. & Munk-Jorgensen, P. (2005). Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases. British Journal of Psychiatry, 187, 510–15.
Armstrong, E., Schleicher, A., Omran, H., Curtis, M. & Zilles, K. (1995). The ontogeny of human gyrification. Cerebral Cortex, 5, 56–63.
Arndt, S., Tyrrell, G., Flaum, M. & Andreasen, N. C. (1992). Comorbidity of substance abuse and schizophrenia: the role of premorbid adjustment. Psychological Medicine, 22, 379–88.
Arseneault, L., Cannon, M., Poulton, R. et al. (2002). Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. British Medical Journal, 325, 1212–13.
Arseneault, L., Cannon, M., Poulton, R. et al. (2002). Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. British Medical Journal, 325, 1212–13.
Arseneault, L., Cannon, M., Witton, J. & Murray, R. M. (2004). Causal association between cannabis and psychosis: examination of the evidence. British Journal of Psychiatry, 184, 110–17.
Arvindakshan, M., Ghate, M., Ranjekar, P. K., Evans, D. R. & Mahadik, S. P. (2003). Supplementation with a combination of omega-3 fatty acids and antioxidants (vitamins E and C) improves the outcome of schizophrenia. Schizophrenia Research, 62, 195–204.
Asato, M. R., Sweeney, J. A. & Luna, B. (2006). Cognitive processes in the development of TOL performance. Neuropsychologia, 44, 2259–69.
Asberg, M., Traskman, L. & Thoren, P. (1976). 5-HIAA in the cerebrospinal fluid: a biochemical suicide predictor? Archives of General Psychiatry, 33, 1193–7.
Asnis, G. M., Halbreich, U., Ryan, N. D. et al. (1987). The relationship of the dexamethasone suppression test (1-mg and 2-mg) to basal plasma cortisol levels in endogenous depression. Psychoneuroendocrinology, 12, 295–301.
Australian Bureau of Statistics (2005). Labour Force Australia: November Key Figures. Canberra: Australian Bureau of Statistics.
Australian Bureau of Statistics (2006). Barriers and Incentives to Labour Force Participation, Australia, August 2004 to June 2005. Canberra: Australian Bureau of Statistics.
Australian Institute for Suicide Research and Prevention (2003). International Suicide Rates: Recent Trends and Implications for Australia. Canberra: Australian Government Department of Health and Ageing.
Avery, D. H., Holtzheimer, P. E., III, Fawaz, W. et al. (2006). A controlled study of repetitive transcranial magnetic stimulation in medication-resistant major depression. Biological Psychiatry, 59, 187–94.
Avramopoulos, D., Stefanis, N. C., Hantoumi, I. et al. (2002). Higher scores of self reported schizotypy in healthy young males carrying the COMT high activity allele. Molecular Psychiatry, 7, 706–11.
Axel, M. (1955). 10 borderline cases: a report on the question of pseudoneurotic schizophrenia. Psychiatric Quarterly, 29, 555–87.
Baaré, W. F., van Oel, C. J., Hulshoff Pol, H. E. et al. (2001). Volumes of brain structures in twins discordant for schizophrenia. Archives of General Psychiatry, 58, 33–40.
Bachmann, S., Bottmer, C., Jacob, S. et al. (2002). Expressed emotion in relatives of first-episode and chronic patients with schizophrenia and major depressive disorder: a comparison. Psychiatry Research, 112, 239–50.
Badner, J. A. & Gershon, E. S. (2002). Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia. Molecular Psychiatry, 7, 405–11.
Baethege, C., Smolka, M. N., Grushka, P. et al. (2003). Does prophylaxis-delay in bipolar disorder influence outcome? Results from a long-term study of 147 patients. Acta Psychiatrica Scandinavica, 107, 260–7.
Bak, M., Myin-Germeys, I., Hanssen, M. et al. (2003). When does experience of psychosis result in a need for care? A prospective general population study. Schizophrenia Bulletin, 29, 349–58.
Baker, A. & Dawe, S. (2005). Amphetamine use and co-occurring psychological problems: review of the literature and implications for treatment. Australian Psychologist, 40, 88–95.
Baker, A. C. & Morrison, P. A. (1998). Cognitive processes in auditory hallucinations: attributional biases and metacognition. Psychological Medicine, 28, 1199–208.
Baker, A., Bucci, S. & Kay-Lambkin, F. (2004). Intervention for Alcohol, Cannabis and Amphetamine Use among People with a Psychotic Illness. [NDARC Technical Report No. 193.] Sydney: National Drug and Alcohol Research Centre.
Baker, A., Bucci, S., Lewin, T. J. et al. (2006a). Cognitive-behavioural therapy for substance use disorders in people with psychotic disorders: randomised controlled trial. British Journal of Psychiatry, 188, 439–48.
Baker, A., Lewin, T., Reichler, H. et al. (2002). Motivational interviewing among psychiatric in-patients with substance use disorders. Acta Psychiatrica Scandinavica, 106, 233–40.
Baker, A., Richmond, R., Haile, M. et al. (2006b). Randomised controlled trial of a smoking cessation intervention among people with a psychotic disorder. American Journal of Psychiatry, 163, 1934–42.
Baker, K. (2005). Mapping the Social Firm Sector 2005. Redhill, UK: Social Firms.
Baldessarini, R. J., Tondo, L. & Hennen, J. (2003). Treatment latency and previous episodes: relationship to pretreatment morbidity and response to maintenance treatment in bipolar I and II disorders. Bipolar Disorders, 5, 169–79.
Balestrieri, M., Bon, M. G., Rodriguez-Sacristan, A. & Tansella, M. (1994). Pathways to psychiatric care in South-Verona, Italy. British Journal of Psychiatry, 24, 641–9.
Ball, R. A., Moore, E. & Kuipers, L. (1992). Expressed emotion in community care staff: a comparison of patient outcome in a nine month follow-up of two hostels. Social Psychiatry and Psychiatric Epidemiology, 27, 35–9.
Barak, Y., Mirecki, I., Knobler, H. Y., Natan, Z. & Aizenberg, D. (2004). Suicidality and second generation antipsychotics in schizophrenia patients: a case-controlled retrospective study during a 5-year period. Psychopharmacology, 175, 215–19.
Barnes, T. R. E. & McEvedy, C. J. B. (1996). Pharmacological treatment strategies in the non-responsive schizophrenic patient. International Clinical Psychopharmacology, 11, 67–71.
Barnes, T. R. E., Hutton, S. B., Chapman, M. J. et al. (2000). West London first-episode study of schizophrenia: clinical correlates of duration of untreated psychosis. British Journal of Psychiatry, 177, 207–11.
Barnes, T. R., Hutton, S. B., Chapman, M. J. et al. (2000). West London first episode study of schizophrenia: clinical correlates of duration of untreated psychosis. British Journal of Psychiatry, 177, 207–11.
Barnes, T. R., Mutsatsa, S. H., Hutton, S. B., Watt, H. C. & Joyce, E. M. (2006). Comorbid substance use and age at onset of schizophrenia. British Journal of Psychiatry, 188, 237–42.
Barnes, T., Hutton, S. B., Chapman, M. J. et al. (2000). West London first-episode study of schizophrenia. Clinical correlates of duration of untreated psychosis. British Journal of Psychiatry, 177, 207–11.
Baron, M. & Gruen, R. (1988). Risk factors in schizophrenia. Season of birth and family history. [See comments.] British Journal of Psychiatry, 152, 460–5.
Baron, R. C. & Salzer, M. S. (2002). Accounting for unemployment among people with mental illness. Behavioural Sciences and the Law, 20, 585–99.
Barrelet, L., Ferrero, F., Szigethy, L., Giddey, C. & Pellizzer, G. (1990). Expressed emotion and first-admission schizophrenia: nine month follow-up in a French cultural environment. British Journal of Psychiatry, 156, 357–62.
Barrelet, L., Ferrero, F., Szigethy, L., Giddey, C. & Pellizzer, G. (1990). Expressed emotion and first-admission schizophrenia: nine-month follow-up in a French cultural environment. British Journal of Psychiatry, 156, 357–62.
Barrowclough, C. & Hooley, J. M. (2003). Attributions and expressed emotion: a review. Clinical Psychology Review, 23, 849–80.
Barrowclough, C., Haddock, G., Lowens, I. et al. (2001). Staff expressed emotion and causal attributions for client problems on a low security unit: an exploratory study. Schizophrenia Bulletin, 27, 517–26.
Barrowclough, C., Haddock, G., Tarrier, N. et al. (2001) Randomized controlled trial of motivational interviewing, cognitive behaviour therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders. American Journal of Psychiatry, 158, 1706–13.
Barrowclough, C., Haddock, G., Tarrier, N. et al. (2001). Randomized controlled trial of motivational interviewing, cognitive behaviour therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders. American Journal of Psychiatry, 158, 1706–13.
Basco, M. R. & Rush, A. J. (1995). Compliance with pharmacology in mood disorders. Psychiatric Annals, 25, 269–79.
Bateson, G., Jackson, D. D., Haley, J. & Weakland, J. (1956). Toward a theory of schizophrenia. Behavioral Science, 1, 251–64.
Battaglia, J., Coverdale, J. H. & Bushong, C. P. (1990). Evaluation of a mental illness awareness week program in public schools. American Journal of Psychiatry, 147, 324–9.
Bauer, M., Bschor, T., Pfennig, A. et al. (2007). World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders in primary care. World Journal of Biological Psychiatry, 8, 67–104.
Bayer, T. A., Falkai, P. & Maier, W. (1999). Genetic and non-genetic vulnerability factors in schizophrenia: the basis of the ‘two hit hypothesis’. Journal of Psychiatric Research, 33, 543–8.
Bebbington, P. & Kuipers, L. (1994). The predictive utility of expressed emotion in schizophrenia: an aggregate analysis. Psychological Medicine, 24, 707–18.
Bebbington, P., Wilkens, S. & Jones, P. (1993). Life events and psychosis. British Journal of Psychiatry, 162, 72–9.
Bebbington, P., Wilkins, S., Jones, P. et al. (1993). Life events and psychosis: initial results from the Camberwell Collaborative Psychosis Study. British Journal of Psychiatry, 162, 72–9.
Bech, P. (1993). Rating Scales for Psychopathology, Health Status and Quality of Life. New York: Springer-Verlag.
Bech, P. (1994). The borderline syndromes of depression, mania and schizophrenia: the coaxial or temperamental approach. Acta Psychiatrica Scandinavica, 89(Suppl), 45–9.
Bechdolf, A., Kohn, D., Knost, B., Pukrop, R. & Klosterkötter, J. (2005b). A randomized comparison of group cognitive–behavioural therapy and group psychoeducation in acute patients with schizophrenia: outcome at 24 months. Acta Psychiatrica Scandinavica, 112, 173–9.
Bechdolf, A., Phillips, L. J., Francey, S. et al. (2006). Recent approaches to psychological interventions for people at risk of psychosis. European Archives of Psychiatry and Neuroscience, 256, 159–73.
Bechdolf, A., Phillips, L. J., Francey, S. M. et al. (2006). Recent approaches to psychological interventions for people at risk of psychosis. European Archives of Psychiatry and Clinical Neuroscience, 256, 159–73.
Bechdolf, A., Pukrop, R., Kohn, D. et al. (2005). Subjective quality of life in subjects at risk for a first episode of psychosis: a comparison with first episode schizophrenia patients and healthy controls. Schizophrenia Research, 79, 137–43.
Bechdolf, A., Ruhrmann, S., Wagner, M. et al. (2005a). Interventions in the initial prodromal states of psychosis in Germany: concept and recruitment. British Journal of Psychiatry, 187, s45–8. [Special Issue: Early Psychosis: A Bridge to the Future.]
Bechdolf, A., Veith, V., Schwarzer, D. et al. (2005c). Cognitive– behavioral therapy in the pre-psychotic phase: an exploratory study. Psychiatry Research, 136, 251–5.
Beck, A. T. (1976). Cognitive Therapy and the Emotional Disorders. New York: International Universities Press.
Beck, A. T. (1996). Foreword. In T. E. Ellis & C. F. Newman (eds.), Chosing to Live. Oakland, CA: New Harbinger, pp. ix–xi.
Beck, A. T., Kovacs, M. & Weissman, A. (1979). Assessment of suicidal ideation: the Scale for Suicide Ideation. Journal of Consulting and Clinical Psychology, 47, 343–52.
Beck, A. T., Rush, A. J., Shaw, B. F. & Emery, G. (1979). Cognitive Therapy of Depression. New York: Guilford Press.
Beck, A., Schuyler, D. & Herman, I. (1974a). Development of suicidal intent scales. In A. T. Beck, H. C. P. Resnik & D. Lettieri (eds.), The Prediction of Suicide. Bowie, MD: Charles Press, pp. 5445–56.
Beck, A., Weissman, A., Lester, D. & Trexler, L. (1974b). The measurement of pessimism: the Hopelessness Scale. Journal of Consulting and Clinical Psychology, 44, 861–5.
Becker, D. & Drake, R. (2003). A Working Life for People with Severe Mental Illness. New York: Oxford Press.
Becker, T., Albert, M., Angermeyer, M. C. & Thornicroft, G. (1997). Social networks and service utilisation in patients with severe mental illness. Epidemiologia e Psichiatria Sociale, 6, 113–25.
Beer, M. D. (1996). The dichotomies: psychosis/neurosis and functional/organic: an historic perspective. History of Psychiatry, vii, 231–55.
Beiser, M., Erickson, D., Fleming, J. A. E. & Iacono, W. G. (1993). Establishing the onset of psychotic illness. American Journal of Psychiatry, 150, 1349–54.
Beiser, M., Erickson, D., Fleming, J. A. E. & Iacono, W. G. (1993). Establishing the onset of psychotic illness. American Journal of Psychiatry, 150, 1349–54.
Bell, M. & Lysaker, P. (1996). Levels of expectation for work activity in schizophrenia: clinical and rehabilitation outcomes. Psychiatric Rehabilitation Journal, 19, 71–6.
Bell, R. Q. (1992). Multiple-risk cohorts and segmenting risk as solutions to the problem of false positives in risk for the major psychoses. Psychiatry, 55, 370–81.
Bellack, A. S. (1986). Schizophrenia: behaviour therapy's forgotten child. Behaviour Therapy, 17, 199–214.
Bellivier, F., Golmard, J. L., Rietschel, M. et al. (2003). Age at onset in bipolar I affective disorder: further evidence for three subgroups. American Journal of Psychiatry, 160, 999–1001.
Benes, F. M. (2007). Searching for unique endophenotypes for schizophrenia and bipolar disorder within neural circuits and their molecular regulatory mechanisms. Schizophrenia Bulletin, 33, 932–6.
Bentall, R. & Kaney, S. (1989). Content specific information processing and persecutory delusions: an investigation using the emotional Stroop test. British Journal of Medical Psychology, 62, 355–64.
Bentall, R. P. & Morrison, A. P. (2002). More harm than good: the case against using antipsychotic drugs to prevent severe mental illness. Journal of Mental Health, 11, 351–6.
Bentall, R. P. & Morrison, A. P. (2002). More harm than good: the case against using antipsychotic drugs to prevent severe mental illness. Journal of Mental Health, 11, 351–6.
Bentsen, H., Boye, B., Munkvold, O. G. et al. (1996). Emotional overinvolvement in parents of patients with schizophrenia or related psychosis: demographic and clinical predictors. British Journal of Psychiatry, 169, 622–30.
Bentsen, H., Notland, T. H., Munkvold, O.-G. et al. (1998). Guilt proneness and expressed emotion in relatives of patients with schizophrenia or related psychoses. British Journal of Medical Psychology, 71, 125–38.
Berger, G., Wood, S. & McGorry, P. (2003). Incipient neurovulnerability and neuroprotection in early psychosis. Psychopharmacology Bulletin, 37, 79–101.
Berk, M. & Dodd, S. (2005). Are treatment emergent suicidality and decreased response to antidepressants in younger patients due to bipolar disorder being misdiagnosed as unipolar depression? Medical Hypotheses, 65, 39–43.
Berk, M., Berk, L., Moss, K., Dodd, S. & Malhi, G. S. (2006). Diagnosing bipolar disorder: how can we do it better? Medical Journal of Australia, 184, 459–62.
Berk, M., Hallam, K., Lucas, N. et al. (2007). Early intervention in bipolar disorders: opportunities and pitfalls. Medical Journal of Australia, 187(Suppl), S11–14.
Berk, M., Malhi, G. S., Cahill, C. et al. (2007). The Bipolar Depression Rating Scale (BDRS): its development, validation and utility. Bipolar Disorder, 9, 571–9.
Berk, M., Malhi, G. S., Mitchell, P. B. et al. (2004). Scale matters: the need for a Bipolar Depression Rating Scale (BDRS). Acta Psychiatrica Scandinavica, 422(Suppl), 39–45.
Bernstein, D. A. & Borkovec, T. D. (1973). Progressive Relaxation Training: A Manual for the Health Professionals. Campaign, IL: Research Press.
Bertelsen, M., Jeppesen, P., Petersen, L. et al. (2007). Suicidal behaviour and mortality in 547 first-episode psychotic patients: the OPUS trial. British Journal of Psychiatry, 51(Suppl), s140–6.
Bertolino, A., Caforio, G., Blasi, G. et al. (2004). Interaction of COMT (Val(108/158)Met) genotype and olanzapine treatment on prefrontal cortical function in patients with schizophrenia. American Journal of Psychiatry, 161, 1798–805.
Bertolino, A., Callicott, J. H., Elman, I. et al. (1998). Regionally specific neuronal pathology in untreated patients with schizophrenia: a proton magnetic resonance spectroscopic imaging study. Biological Psychiatry, 43, 641–8.
Bertolote, J. & McGorry, P. D. (2005). Early intervention and recovery for young people with early psychosis: consensus statement. British Journal of Psychiatry, 187(Suppl), s116–19.
Bhugra, D. (2000). Migration and schizophrenia. Acta Psychiatrica Scandinavica Supplementum, 102, 68–73.
Bhugra, D., Bhamra, J. & Taylor, P. (1997). Users views of a drop-in project for the homeless. International Journal of Social Psychiatry, 43, 95–103.
Bhugra, D., Corridan, B., Rudge, S., Leff, J. & Mallett, R. (1999). Early manifestations, personality traits and pathways to care for Asian and white first-onset cases of schizophrenia. Social Psychiatry and Psychiatric Epidemiology. 34, 595–9.
Bhugra, D., Hilwig, M., Mallett, R. et al. (2000). Factors in the onset of schizophrenia: a comparison between London and Trinidad samples. Acta Psychiatrica Scandinavica, 101, 135–41.
Bhugra, D., Leff, J., Mallett, R., Der, G. B. C. & Rudge, S. (1997). Incidence and outcome of schizophrenia in Whites, African-Caribbeans and Asians in London. Psychological Medicine, 27, 791–8.
Bibou-Nakou, I., Dikaiou, M. & Bairactaris, C. (1997). Psychosocial dimensions of family burden among two groups of carers looking after psychiatric patients. Social Psychiatry and Psychiatric Epidemiology, 32, 104–8.
Bilby, R. (1992). A response to the criticisms of transitional employment. Psychosocial Rehabilitation Journal. Special Issue: The Clubhouse Model, 16, 69–82.
Bilder, R. M., Goldman, R. S., Robinson, D. et al. (2000). Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates. American Journal of Psychiatry, 157, 549–59.
Bilder, R. M., Goldman, R. S., Robinson, D. et al. (2000). Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates. American Journal of Psychiatry, 157, 549–59.
Bilder, R. M., Volavka, J., Czobor, P. et al. (2002). Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia. Biological Psychiatry, 52, 701–7.
Biostat. Comprehensive Meta-Analysis Version 1.0.23. Englewood, NJ: Biostat. http//www.Meta-Analysis.com (accessed 13 February 2004).
Birchwood, M. & Chadwick, P. (1997). The omnipotence of voices: testing the validity of a cognitive model. Psychological Medicine, 27, 1345–53.
Birchwood, M. & Fiorillo, A. (2000). The critical period for early intervention. Psychiatric Rehabilitation Skills, 4, 182–98.
Birchwood, M. & Fiorillo, A. (2000). The critical period for early intervention. Psychiatric Rehabilitation Skills. Special Issue: The British Approach to Psychiatric Rehabilitation, 4, 182–98.
Birchwood, M. & Spencer, E. (2001). Early intervention in psychotic relapse. Clinical Psychology Review Special Issue: Psychosis, 21, 1211–26.
Birchwood, M. & Trower, P. (2006). The future of cognitive–behavioural therapy for psychosis: not a quasi-neuroleptic. British Journal of Psychiatry, 188, 107–8.
Birchwood, M. (1999). Early intervention in psychosis: the critical period. In P. D. McGorry & H. J. Jackson (eds.), The Recognition and Management of Early Psychosis: A Preventive Approach. New York: Cambridge University Press, pp. 226–64.
Birchwood, M. (2003). Editorial: pathways to emotional dysfunction in psychosis. British Journal of Psychiatry, 182, 373–5.
Birchwood, M., Iqbal, Z., Chadwick, P. & Trower, P. (2000). Cognitive approach to depression and suicidal thinking in psychosis: ontogeny of post-psychotic depression. British Journal of Psychiatry, 177, 516–21.
Birchwood, M., Iqbal, Z., Chadwick, P. & Trower, P. (2000a). Cognitive approach to depression and sucidal thinking in psychosis. 1. Ontogeny of post-psychotic depression. British Journal of Psychiatry, 177, 516–21.
Birchwood, M., Mason, R., MacMillan, F. & Healy, J. (1993). Depression, demoralization and control over psychotic illness: a comparison of depressed and non-depressed patients with a chronic psychosis. Psychological Medicine, 23, 387–95.
Birchwood, M., Meaden, A., Trower, P. Gilbert, P. & Plaistow, J. (2000b). The power and omnipotence of voices, subordination and entrapment by voices and significant others. Psychological Medicine, 30, 337–44.
Birchwood, M., Smith, J., Cochrane, R., Wetton, S. & Copestake, S. (1990). The Social Functioning Scale. The development and validation of a new scale of social development for use in family intervention programmes with schizophrenic patients. British Journal of Psychiatry, 157, 853–9.
Birchwood, M., Smith, J., Drury, V. et al. (1994). A self-report insight scale for psychosis: reliability, validity and sensitivity to change. Acta Psychatrica Scandinavica, 89, 62–7.
Birchwood, M., Smith, J., Macmillan, F. et al. (1989). Predicting relapse in schizophrenia: the development of an early signs monitoring system using patients and families as observers, a preliminary investigation. Psychological Medicine, 19, 649–56.
Birchwood, M., Todd, P. & Jackson, C. (1998). Early intervention in psychosis: the critical period hypothesis. British Journal of Psychiatry, 172(Suppl 33), s53–9.
Birchwood, M., Todd, P. & Jackson, C. (1998). Early intervention in psychosis: the critical period hypothesis. British Journal of Psychiatry, 33(Suppl), s53–9.
Birchwood, M., Trower, P., Brunet, K. et al. (2007). Social anxiety and the shame of psychosis. Behaviour Research and Therapy, 45, 1025–37.
Birley, J. L. T. & Brown, G. W. (1970). Crises and life changes preceding the onset or relapse of acute schizophrenia. British Journal of Psychiatry, 116, 327–33.
Black, K., Peters, L., Rui, Q. et al. (2001). Duration of untreated psychosis predicts treatment outcome in an early psychosis program. Schizophrenia Research, 47, 215–22.
Black, K., Peters, L., Rui, Q. et al. (2001). Duration of untreated psychosis predicts treatment outcome in an early psychosis program. Schizophrenia Research, 47, 215–22.
Blackwood, D. H., Fordyce, A., Walker, M. T. et al. (2001). Schizophrenia and affective disorders – cosegregation with a translocation at chromosome 1q42 that directly disrupts brain-expressed genes: clinical and P300 findings in a family. American Journal of Human Genetics, 69, 428–33.
Blackwood, D. H., Fordyce, A., Walker, M. T. et al. (2001). Schizophrenia and affective disorders: cosegregation with a translocation at chromosome 1q42 that directly disrupts brain-expressed genes: clinical and P300 findings in a family. American Journal of Human Genetics, 69, 428–33.
Blackwood, D. H., St Clair, D. M., Muir, W. J. & Duffy, J. C. (1991). Auditory P300 and eye tracking dysfunction in schizophrenic pedigrees. Archives of General Psychiatry, 48, 899–909.
Blanchard, J. J., Brown, S. A., Horan, W. P. & Sherwood, A. R. (2000). Substance use disorders in schizophrenia: review, integration, and a proposed model. Clinical Psychology Review, 20, 207–34.
Blanchard, J. J., Squires, D., Henry, T. et al. (1999). Examining an affect regulation model of substance abuse in schizophrenia: the role of traits and coping. Journal of Nervous and Mental Disease, 187, 72–9.
Bland, R. C., Parker, J. H. & Orn, H. (1978). Prognosis in schizophrenia. Archives of General Psychiatry, 35, 72–7.
Blier, P. & Szabo, S. T. (2005). Potential mechanisms of action of atypical antipsychotic medications in treatment-resistant depression and anxiety. Journal of Clinical Psychiatry, 66(Suppl 8), 30–40.
Blumenthal, S. (1990). Youth suicide: risk factors, assessment, and treatment of adolescent and young adult suicidal patients. Psychiatric Clinics of North America, 13, 511–56.
Boardman, J., Grove, B., Perkins, R. & Shepherd, G. (2003). Work and employment for people with psychiatric disabilities. British Journal of Psychiatry, 182, 467–8.
Bogerts, B., Ashtari, M., Degreef, G. et al. (1990). Reduced temporal limbic structure volumes on magnetic resonance images in first episode schizophrenia. Psychiatry Research, 35, 1–13.
Bogerts, B., Lieberman, J. A., Ashtari, M. et al. (1993). Hippocampus–amygdala volumes and psychopathology in chronic schizophrenia. Biological Psychiatry, 33, 236–46.
Bola, J. R. & Mosher, L. R. (2002). At issue: predicting drug-free treatment response in acute psychosis from the Soteria project. Schizophrenia Bulletin, 28, 559–75.
Bond, G. R. (2004). Supported employment: evidence for an evidence-based practice. Psychiatric Rehabilitation Journal, 27, 345–59.
Bond, G. R., Becker, D. R., Drake, R. E. & Vogler, K. (1997). A fidelity scale for the individual placement and support model of supported employment. Rehabilitation and Counselling Bulletin, 40, 265–84.
Bond, W. S. & Hussar, D. A. (1991). Detection methods and strategies for improving medication compliance. American Journal of Hospital Pharmacy, 48, 1978–88.
Bonnici, H. M., William, T., Moorhead, J. et al. (2007). Pre-frontal lobe gyrification index in schizophrenia, mental retardation and comorbid groups: an automated study. Neuroimage, 53, 648–54.
Bookheimer, S. Y., Strojwas, M. H., Cohen, M. S. et al. (2000). Patterns of brain activation in people at risk for Alzheimer's disease. New England Journal of Medicine, 343, 450–6.
Boos, H. B., Aleman, A., Cahn, W., Pol, H. H. & Kahn, R. S. (2007). Brain volumes in relatives of patients with schizophrenia: a meta-analysis. Archives of General Psychiatry, 64, 297–304.
Bottlender, R., Sato, T., Jager, M. et al. (2002). The impact of duration of untreated psychosis and premorbid functioning on outcome of first inpatient treatment in schizophrenic and schizoaffective patients. European Archives of Psychiatry and Clinical Neuroscience, 252, 226–31.
Bottlender, R., Sato, T., Jager, M. et al. (2003). The impact of the duration of untreated psychosis prior to first psychiatric admission on the 15-year outcome in schizophrenia. Schizophrenia Research, 62, 37–44.
Bottlender, R., Strauss, A. & Moller, H. (2000). Impact of duration of symptoms prior to first hospitalization on acute outcome in 998 schizophrenic patients. Schizophrenia Research, 44, 145–50.
Bowden, C. L. (2005). Treatment options for bipolar depression. Journal of Clinical Psychiatry, 66(Suppl 1), 3–6.
Brady, J. (2006). The association between alcohol misuse and suicidal behaviour. Alcohol and Alcoholism, 41, 473–8.
Braff, D. L., Freedman, R., Schork, N. J. & Gottesman, II. (2007). Deconstructing schizophrenia: an overview of the use of endophenotypes in order to understand a complex disorder. Schizophrenia Bulletin, 33, 21–32.
Bramon, E., Shaikh, M., Broome, M. et al. (2008). Abnormal P300 in people with high risk of developing psychosis. Neuroimage, 41, 553–60.
Breitborde, N. J. K., López, S. R., Wickens, T. D., Jenkins, J. H. & Karno, M. (2007). Toward specifying the nature of the relationship between expressed emotion and schizophrenic relapse: the utility of curvilinear models. International Journal of Methods in Psychiatric Research, 16, 1–10.
Brenner, H. D., Dencker, S. J., Goldstein, M. J. et al. (1990). Defining treatment refractoriness in schizophrenia. Schizophrenia Bulletin, 16, 551–61.
Brent, D. A. & Mann, J. J. (2005). Family genetic studies, suicide, and suicidal behaviour. American Journal of Medical Genetics: Seminars in Medical Genetics, 133, 13–24.
Brewer, W. J., Francey, S. M., Wood, S. J. et al. (2005). Memory impairments identified in people at ultra-high risk for psychosis who later develop first-episode psychosis. American Journal of Psychiatry, 162, 71–8.
Brewer, W. J., Francey, S. M., Wood, S. J. et al. (2005). Memory impairments identified in people at ultra-high risk for psychosis who later develop first-episode psychosis. American Journal of Psychiatry, 162, 71–8.
Brewer, W. J., Murphy, B., Lambert, T. et al. (2006). Intensive case management (ICM) for high suicide risk: evaluating a unique model of care for poorly engaged clients with first episode psychosis. Schizophrenia Research, 81(Suppl 1), 229.
Brewer, W. J., Pantelis, C., Anderson, V. et al. (2001). Stability of olfactory identification deficits in neuroleptic-naive patients with first-episode psychosis. American Journal of Psychiatry, 158, 107–15.
Brewer, W. J., Pantelis, C., De Luca, C. R. & Wood, S. J. (2006b). Olfactory processing and brain maturation. In W. J. Brewer, D. J. Castle & C. Pantelis (eds.), Olfaction and the Brain. Cambridge, UK: Cambridge University Press, pp. 103–18.
Brewer, W. J., Wood, S. J., McGorry, P. D. et al. (2003). Impairment of olfactory identification ability in individuals at ultra-high risk for psychosis who later develop schizophrenia. American Journal of Psychiatry, 160, 1790–4.
Brewer, W. J., Wood, S. J., Phillips, L. J. et al. (2006). Generalised and specific cognitive performance in clinical high-risk cohorts: a review highlighting potential vulnerability markers for psychosis. Schizophrenia Bulletin, 32, 538–55.
Brewer, W. J., Wood, S. J., Phillips, L. J. et al. (2006a). Generalized and specific cognitive performance in clinical high-risk cohorts: a review highlighting potential vulnerability markers for psychosis. Schizophrenia Bulletin, 32, 538–55.
Brewer, W. J., Yucel, M., Harrison, B. J. et al. (2007). Increased prefrontal cerebral blood flow in first-episode schizophrenia following treatment: longitudinal positron emission tomography study. Australian and New Zealand Journal of Psychiatry, 41, 129–35.
Brockhaus-Dumke, A., Schultze-Lutter, F., Müller, R. et al. (2008). Sensory gating in schizophrenia: P50 and N100 gating in antipsychotic-free subjects at risk, first-episode and chronic patients. Biological Psychiatry, Epub: 10.1016/j.biopsych.2008.02.006.
Brockhaus-Dumke, A., Tendolkar, I., Pukrop, R. et al. (2005). Impaired mismatch negativity generation in prodromal subjects and patients with schizophrenia. Schizophrenia Research, 73, 297–310.
Bromet, E. J., Finch, S. J., Carlson, G. A. et al. (2005). Time to remission and relapse after the first hospital admission in severe bipolar disorder. Social Psychiatry and Psychiatric Epidemiology, 40, 106–13.
Bronisch, T. (1996). The relationship between suicidality and depression. Archives of Suicide Research, 2, 235–54.
Broome, M. R., Woolley, J. B., Johns, L. C. et al. (2005). Outreach and support in south London (OASIS): implementation of a clinical service for prodromal psychosis and the at risk mental state. European Psychiatry, 20, 372–8.
Broome, M. R., Woolley, J. B., Tabraham, P. et al. (2005). What causes the onset of psychosis? Schizophrenia Research, 79, 23–34.
Brown, G. & Birley, J. (1968). Crises and life changes and the onset of schizophrenia. Journal of Health and Social Behaviour, 9, 203–14.
Brown, G. W. (1985). The discovery of expressed emotion: induction or deduction? In J. Leff & C. Vaughn (eds.), Expressed Emotion in Families. New York: Guilford Press, pp. 7–25.
Brown, G. W., Andrews, B., Bifulco, A. & Veiel, H. (1990). Self-esteem and depression. 1: Measurement issues and prediction of onset. Social Psychiatry and Psychiatric Epidemiology, 25, 200–9.
Brown, G. W., Carstairs, G. M. & Topping, G. (1962). Influence of family life on the course of schizophrenic illness. British Journal of Preventive and Social Medicine, 16, 55.
Brown, G. W., Carstairs, G. M. & Topping, G. G. (1958). Post-hospital adjustment of chronic mental patients. Lancet, ii, 685–9.
Brown, S. & Birtwistle, J. (1998). People with schizophrenia and their families: fifteen-year outcome. British Journal of Psychiatry, 173, 139–44.
Brown, S. (1997). Excess mortality of schizophrenia: a meta-analysis. British Journal of Psychiatry, 171, 502–8.
Brown, S., Barraclough, B. & Inskip, H. (2000). Causes of the excess mortality of schizophrenia. British Journal of Psychiatry, 177, 212–17.
Browne, S., Clarke, M., Gervin, M. et al. (2000). Determinants of quality of life at first presentation with schizophrenia. British Journal of Psychiatry, 176, 173–6.
Browne, S., Larkin, C. & O'Callaghan, E. (1999). Outcome studies in schizophrenia. Irish Journal of Psychological Medicine, 16, 140–4.
Buckley, P. F. & Shendarkar, N. (2005). Treatment-refractory schizophrenia. Current Opinion in Psychiatry, 18, 165–73.
Buckley, P., Miller, A., Olsen, J. et al. (2001). When symptoms persist: clozapine augmentation strategies. Schizophrenia Bulletin, 27, 615–28.
Burgess, P., Pirkis, J., Morton, J. & Croke, E. (2000). Lessons from a comprehensive clinical audit of users of psychiatric services who committed suicide. Psychiatric Services, 51, 1555–60.
Burke, K. C., Burke, J. D., Regier, D. A., Rae, D. S. (1990). Age at onset of selected mental disorders in five community populations. Archives of General Psychiatry, 47, 511–18.
Burnett, R., Mallett, R., Bhugra, D. et al. (1999). The first contact of patients with schizophrenia with psychiatric services: social factors and pathways to care in a multi-ethnic population. Psychological Medicine, 29, 475–83.
Burns, T., Fiander, M. & Audini, B. (2000). A Delphi approach to characterising ‘relapse’ as used in UK clinical practice. International Journal of Social Psychiatry, 46, 220–30.
Butzlaff, R. L. & Hooley, J. M. (1998). Expressed emotion and psychiatric relapse. Archives of General Psychiatry, 55, 547–52.
Byrne, M., Agerbo, E., Ewald, H., Eaton, W. W. & Mortensen, P. B. (2003). Parental age and risk of schizophrenia: a case– control study. Archives of General Psychiatry, 60, 673–8.
Byrne, M., Hodges, A., Grant, E., Owens, D. G. & Johnstone, E. C. (1999). Neuropsychological assessment of young people at high genetic risk for developing schizophrenia compared with controls: preliminary findings of the Edinburgh High Risk Study (EHRS). Psychological Medicine, 29, 1161–73.
Cachia, A., Paillere-Martinot, M. L., Galinowski, A. et al. (2008). Cortical folding abnormalities in schizophrenia patients with resistant auditory hallucinations. Neuroimage, 39, 927–35.
Cadenhead, K. (2002). Vulnerability markers in the schizophrenia spectrum: implications for phenomenology, genetics and the identification of the schizophrenia prodrome. Psychiatric Clinics of North America, 25, 837–53.
Cadenhead, K. S., Light, G. A., Geyer, M. A. & Braff, D. L. (2000). Sensory gating deficits assessed by the P50 event-related potential in subjects with schizotypal personality disorder. American Journal of Psychiatry, 157, 55–9.
Cadenhead, K. S., Light, G. A., Shafer, K. M. & Braff, D. L. (2005). P50 suppression in individuals at risk for schizophrenia: the convergence of clinical, familial, and vulnerability marker risk assessment. Biological Psychiatry, 57, 1504–9.
Caldwell, T. M. & Jorm, A. F. (2000). Mental health nurses' beliefs about interventions for schizophrenia and depression: a comparison with psychiatrists and the public. Australian and New Zealand Journal of Psychiatry, 34, 602–11.
Callicott, J. H., Straub, R. E., Pezawas, L. et al. (2005). Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia. Proceedings of the National Academy of Sciences USA, 102, 8627–32.
Callicott, J. H., Straub, R. E., Pezawas, L. et al. (2005). Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia. Proceedings of the National Academy of Sciences USA, 102, 8627–32.
Camargo, L. M., Collura, V., Rain, J. C. et al. (2007). Disrupted in schizophrenia 1 interactome: evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia. Molecular Psychiatry, 12, 74–86.
Canadian Psychiatric Association (2005). Clinical practice guidelines for schizophrenia. Canadian Journal of Psychiatry, 50(Suppl 1).
Canadian Psychiatric Association Working Group (2005). Clinical practice guidelines for treatment of schizophrenia. Canadian Journal of Psychiatry, 50(Suppl 1), 1s–56s.
Cannon, M. & Clarke, M. C. (2005). Risk for schizophrenia: broadening the concepts, pushing back the boundaries. Schizophrenia Research, 79, 5–13.
Cannon, M., Jones, P., Gilvarry, C. et al. (1997). Premorbid social functioning in schizophrenia and bipolar disorder: similarities and differences. American Journal of Psychiatry, 154, 1544–50.
Cannon, T. D. & Mednick, S. A. (1993). The schizophrenia high-risk project in Copenhagen: three decades of progress. Acta Psychiatrica Scandinavica, 370(Suppl), 33–47.
Cannon, T. D. (2005a). Clinical and genetic high-risk strategies in understanding vulnerability to psychosis. Schizophrenia Research, 79, 35–44.
Cannon, T. D. (2005b). The inheritance of intermediate phenotypes for schizophrenia. Current Opinion in Psychiatry, 18, 135–40.
Cannon, T. D., Bearden, C. E., Hollister, J. M. et al. (2000). Childhood cognitive functioning in schizophrenia patients and their unaffected siblings: a prospective cohort study. Schizophrenia Bulletin, 26, 379–93.
Cannon, T. D., Hennah, W., van Erp, T. G. et al. (2005). Association of DISC1/TRAX haplotypes with schizophrenia, reduced prefrontal gray matter, and impaired short- and long-term memory. Archives of General Psychiatry, 62, 1205–13.
Cannon, T. D., Mednick, S. A., Parnas, J. et al. (1993). Developmental brain abnormalities in the offspring of schizophrenic mothers. I. Contributions of genetic and perinatal factors [see comments]. Archives of General Psychiatry, 50, 551–64.
Cannon, T. D., Thompson, P. M., van Erp, T. G. et al. (2002). Cortex mapping reveals regionally specific patterns of genetic and disease-specific gray-matter deficits in twins discordant for schizophrenia. Proceedings of the National Academy of Sciences, USA, 99, 3228–33.
Cannon, T. D., van Erp, T. G., Bearden, C. E. et al. (2003). Early and late neurodevelopmental influences in the prodrome to schizophrenia: contributions of genes, environment, and their interactions. Schizophrenia Bulletin, 29, 653–69.
Cannon, T. D., van Erp, T. G., Rosso, I. M. et al. (2002). Fetal hypoxia and structural brain abnormalities in schizophrenic patients, their siblings, and controls. Archives of General Psychiatry, 59, 35–41.
Cannon, T., Huttunen, M., Lonnqvist, J. et al. (2000). The inheritance of neuropsychological dysfunction in twins discordant for schizophrenia. American Journal of Human Genetics, 67, 369–82.
Cannon-Spoor, H. E., Potkin, S. G. & Wyatt, R. J. (1982). Measurement of premorbid adjustment in chronic schizophrenia. Schizophrenia Bulletin, 8, 470–84.
Cannon-Spoor, H. E., Potkin, S. G. & Wyatt, R. J. (1982). Measurement of premorbid adjustment in chronic schizophrenia. Schizophrenia Bulletin, 8, 470–84.
Cannon-Spoor, H. E., Potkin, S. G. & Wyatt, R. J. (1982). Measurement of premorbid adjustment in chronic schizophrenia. Schizophrenia Bulletin, 8, 470–84.
Canoll, P. D., Kraemer, R., Teng, K. K., Marchionni, M. A. & Salzer, J. L. (1999). GGF/neuregulin induces a phenotypic reversion of oligodendrocytes. Molecular and Cellular Neuroscience, 13, 79–94.
Canton, G. & Fraccon, I. G. (1985). Life events and schizophrenia: a replication. Acta Psychiatrica Scandanivica, 71, 211–16.
Cantwell, R., Brewin, J., Glazebrook, C. et al. (1999). Prevalence of substance misuse in first-episode psychosis. British Journal of Psychiatry, 174, 150–3.
Carbone, S., Harrigan, S., McGorry, P. D., Curry, C. & Elkins, K. (1999). Duration of untreated psychosis and 12 month outcome in first-episode psychosis: the impact of treatment approach. Acta Psychiatrica Scandinavica, 100, 96–104.
Carbone, S., Harrigan, S., McGorry, P., Curry, C. & Elkins, K. (1999). Duration of untreated psychosis and 12-month outcome in first-episode psychosis: the impact of treatment approach. Acta Psychiatrica Scandinavica, 100, 96–104.
Carlson, G. A., Bromet, E. J. & Sievers, S. (2000). Phenomenology and outcome of subjects with early- and adult-onset psychotic mania. American Journal of Psychiatry, 157, 213–19.
Carlsson, R., Nyman, H., Ganse, G. & Cullberg, J. (2006) Neuropsychological functions predict 1- and 3-year outcome in first-episode psychosis. Acta Psychiatrica Scandinavica, 113, 102–11.
Carlyle, T. (1899; reprinted 1969). Critical and Miscellaneous Essays, vol. VI. [The Works of Thomas Carlyle, vol. 29.] New York: AMS Press.
Caroff, S. N., Mann, S. C., Campbell, E. C. & Sullivan, K. A. (2002). Movement disorders associated with atypical antipsychotic drugs. Journal of Clinical Psychiatry, 63(Suppl 4), 12–19.
Carroll, B. J. (1985). Dexamethasone suppression test: a review of contemporary confusion. Journal of Clinical Psychiatry, 46, 13–24.
Carter, C. S., Perlstein, W., Ganguli, R. et al. (1998). Functional hypofrontality and working memory dysfunction in schizophrenia. American Journal of Psychiatry, 155, 1285–7.
Carter, J. W., Parnas, J., Cannon, T. D., Schulsinger, F. & Mednick, S. A. (1999). MMPI variables predictive of schizophrenia in the Copenhagen High-Risk Project: a 25-year follow-up. Acta Psychiatrica Scandinavica, 99, 432–40.
Carter, J. W., Schulsinger, F., Parnas, J., Cannon, T. & Mednick, S. A. (2002). A multivariate prediction model of schizophrenia. Schizophrenia Bulletin, 28, 649–82.
Caspi, A. & Moffitt, T. E. (2006). Gene–environment interactions in psychiatry: joining forces with neuroscience. Nature Review Neuroscience, 7, 583–90.
Caspi, A., McClay, J., Moffitt, T. E. et al. (2002). Role of genotype in the cycle of violence in maltreated children. Science, 297, 851–4.
Caspi, A., Moffitt, T. E., Cannon, M. et al. (2005). Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the COMT gene: longitudinal evidence of a gene × environment interaction. Biological Psychiatry, 57, 1117–27.
Caspi, A., Moffitt, T. E., Cannon, M. et al. (2005). Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biological Psychiatry, 57, 1117–27.
Caspi, A., Moffitt, T. E., Cannon, M. et al. (2005). Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene x environment interaction. Biological Psychiatry, 57, 1117–27.
Caspi, A., Sugden, K., Moffitt, T. E. et al. (2003). Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science, 301, 386–9.
Cassano, G. B., Pini, S., Saettoni, M. & Dell'Osso, L. (1999). Multiple anxiety disorder comorbidity in patients with mood spectrum disorders with psychotic features. American Journal of Psychiatry, 156, 474–6.
Cassidy, F., Roche, S., Claffey, E. & McKeon, P. (2006). First family-based test for association of neuregulin with bipolar affective disorder. Molecular Psychiatry, 11, 706–7.
Caton, C. L., Hasin, D. S., Shrout, P. E. et al. (2006). Predictors of psychosis remission in psychotic disorders that co-occur with substance use. Schizophrenia Bulletin, 32, 618–25.
Catts, S. V., O'Toole, B., Carr, V. et al. (2005). The feasibility of routine effectiveness evaluation in public mental health services: what does it take? Australian and New Zealand Journal of Psychiatry, 39(Suppl 2), A85.
Catts, S. V., Shelley, A. M., Ward, P. B. et al. (1995). Brain potential evidence for an auditory sensory memory deficit in schizophrenia. American Journal of Psychiatry, 152, 213–19.
Chadwick, P. & Birchwood, M. (1994). The omnipotence of voices. A cognitive approach to auditory hallucinations. British Journal of Psychiatry, 164, 190–201.
Chadwick, P. D. & Lowe, C. F. (1990). Measurement and modification of delusional beliefs. Journal of Consulting and Clinical Psychology, 58, 225–32.
Chadwick, P., Birchwood, M. & Trower, P. (1996). Cognitive Therapy for Delusions, Voices and Paranoia. Chichester, UK: John Wiley.
Chadwick, P., Birchwood, M. & Trower, P. (1996). Cognitive Therapy for Delusions, Voices and Paranoia. New York: John Wiley.
Chambers, R. A., Krystal, J. H. & Self, D. W. (2001). A neurobiological basis for substance abuse comorbidity in schizophrenia. Biological Psychiatry, 50, 71–83.
Chambless, D. L. & Steketee, G. (1999). Expressed emotion and behavior therapy outcome: a prospective study with obsessive-compulsive and agoraphobic outpatients. Journal of Consulting and Clinical Psychology, 67, 658–65.
Chance, S. (1997). Stronger than Death: When Suicide Touches Your Life. New York: W. W. Norton.
Chanen, A. M., Jackson, H. J., McGorry, P. D. et al. (2004). Two-year stability of personality disorder in older adolescent outpatients. Journal of Personality Disorders, 18, 526–41.
Chang, K., Karchemskiy, A., Barnea-Goraly, N. et al. (2005). Reduced amygdala gray matter volume in familial pediatric bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 44, 565–73.
Chanpattana, W. & Kramer, B. A. (2004). Acute and maintenance ECT with flupenthixol in refractory schizophrenia: sustained improvement in psychopathology, quality of life and social outcomes. Schizophrenia Research, 66, 177–81.
Chanpattana, W., Chakrabhand, M. L., Kongaskon, R., Techakasem, P. & Buppanharun, W. (1999). Short-term effect of combined ECT and neuroleptic therapy in treatment-resistant schizophrenia. Journal of ECT, 15, 129–39.
Chen, E. Y-H., Dunn, E. L-W., Miao, M. Y-K. et al. (2005). The impact of family experience on the duration of untreated psychosis (DUP) in Hong Kong. Social Psychiatry and Psychiatric Epidemiology, 40, 350–6.
Chen, E. Y.-H., Hui, C. L.-M., Dunn, E. L.-W. et al. (2005). A prospective 3-year longitudinal study of cognitive predictors of relapse in first-episode schizophrenic patients. Schizophrenia Research, 77, 99–104.
Chen, X., Wang, X., O'Neill, A. F., Walsh, D. & Kendler, K. S. (2004). Variants in the catechol-O-methyltransferase (COMT) gene are associated with schizophrenia in Irish high-density families. Molecular Psychiatry, 9, 962–7.
Chi, J., Dooling, E. & Gilles, F. (1977). Gyral development of the human brain. Annals of Neurology, 1, 86–93.
Chong, S-A., Mythily, S. & Verma, S. (2005b). Reducing the duration of untreated psychosis and changing help-seeking behaviour in Singapore. Social Psychiatry and Psychiatric Epidemiology, 40, 619–21.
Chong, S-A., Mythily, S., Lum, A., Chan, Y. H. & McGorry, P. D. (2005a). Determinants of duration of untreated psychosis and the pathway to care in Singapore. International Journal of Social Psychiatry, 51, 55–62.
Chong, S. A., Mythily, S. & Verma, S. (2005). Reducing the duration of untreated psychosis and changing help-seeking behaviour in Singapore. Social Psychiatry and Psychiatric Epidemiology, 40, 619–21.
Chong, S., Mythily, Lum, A., Chan, Y. H. & McGorry, P. (2005). Determinants of duration of untreated psychosis and the pathway to care in Singapore. International Journal of Social Psychiatry, 51, 55–62.
Chowdari, K. V., Mirnics, K., Semwal, P. et al. (2002). Association and linkage analyses of RGS4 polymorphisms in schizophrenia. Human Molecular Genetics, 11, 1373–80.
Christiana, J. M., Gilman, S. E., Guardino, M. et al. (2000). Duration between onset and time of obtaining initial treatment among people with anxiety and mood disorders: an international survey of members of mental health patient advocate groups. Psychological Medicine, 30, 693–703.
Chumakov, I., Blumenfeld, M., Guerassimenko, O. et al. (2002). Genetic and physiological data implicating the new human gene G72 and the gene for d-amino acid oxidase in schizophrenia. Proceedings of the National Academy of Sciences USA, 99, 13675–80.
Chung, R. K., Langeluddecke, P. & Tennant, C. (1986). Threatening life events in the onset of schizophrenia, schizophreniform psychosis and hypomania. British Journal of Psychiatry, 148, 680–5.
Chung, R. K., Langeluddecke, P. & Tennant, C. (1986). Threatening life events in the onset of schizophrenia, schizophreniform psychosis and hypomania. British Journal of Psychiatry, 148, 680–5.
Clark, D. M. & Wells, A. (1995). A cognitive model of social phobia. In R. G. Heimberg, M. R. Liebowitz & D. A. Hope (eds.), Social Phobia: Diagnosis, Assessment, and Treatment, New York: Guilford Press, pp. 69–93.
Clarke, M., Whitty, P., Browne, S. et al. (2006). Suicidality in first episode psychosis. Schizophrenia Research, 86, 221–5.
Cochran, S. D. (1984). Preventing medical noncompliance in the outpatient treatment of bipolar affective disorders. Journal of Consulting and Clinical Psychology, 52, 873–8.
Cohen, J. (1992). A power primer. Psychological Bulletin, 112, 155–9.
Cohen, R. Z., Gotowiec, A. & Seeman, M. V. (2000). Duration of pretreatment phases in schizophrenia: women and men. Canadian Journal of Psychiatry, 45, 544–7.
Coldham, E. L., Addington, J. & Addington, D. (2002). Medication adherence of individuals with a first episode of psychosis. Acta Psychiatrica Scandinavica, 106, 286–90.
Coldham, E. L., Addington, J. & Addington, D. (2002). Medication adherence of individuals with a first episode of psychosis. Acta Psychiatrica Scandinavica, 106, 286–90.
Coldham, E. L., Addington, J. & Addington, D. (2002). Medication adherence of individuals with a first episode of psychosis. Acta Psychiatrica Scandinavica, 106, 286–90.
Coldham, E. L., Addington, J. & Addington, D. (2002). Medication adherence of individuals with a first episode of psychosis. Acta Psychiatrica Scandinavica, 106, 286–90.
Cole, E., Leavey, G., King, M., Johnson-Sabine, E. & Hoar, A. (1995). Pathways to care for patients with a first episode of psychosis: a comparison of ethnic groups. British Journal of Psychiatry, 167, 770–6.
Cole, E., Leavey, G., King, M., Johnson-Sabine, E. & Hoar, A. (1995). Pathways to care for patients with a first episode of psychosis: a comparison of ethnic groups. British Journal of Psychiatry, 167, 770–6.
Colhoun, H. M., McKeigue, P. M. & Davey-Smith, G. (2003). Problems of reporting genetic associations with complex outcomes. Lancet, 361, 865–72.
Colom, F. & Vieta, E. (2004). A perspective on the use of psychoeducation, cognitive-behavioral therapy and interpersonal therapy for bipolar patients. Bipolar Disorders, 6, 480–6.
Colom, F., Vieta, E., Martinez-Aran, A. et al. (2003). A randomized trial on the efficacy of group psychoeducation in the prophylaxis of recurrence in bipolar patients whose disease is in remission. Archives of General Psychiatry, 60, 402–7.
Colom, F., Vieta, E., Martinez-Aran, A. et al. (2003). A randomized trial on the efficacy of group psychoeducation in the prophylaxis of recurrences in bipolar patients whose disease is in remission. Archives of General Psychiatry, 60, 402–7.
Compton, M. T., Kaslow, N. J. & Walker, E. F. (2004). Observations on parent/family factors that may influence the duration of untreated psychosis among African American first-episode schizophrenia patients. Schizophrenia Research, 68, 373–85.
Compton, M. T., Rudisch, B. E., Weiss, P. S., West, J. C. & Kaslow, N. J. (2005). Predictors of psychiatrist-reported treatment-compliance problems among patients in routine US psychiatric care. Psychiatry Research, 137, 29–36.
Conley, R. R. & Buchanan, R. W. (1997). Evaluation of treatment-resistant schizophrenia. Schizophrenia Bulletin, 23, 663–74.
Conley, R. R., Carpenter, W. R. J. & Taminga, C. A. (1997). Time to response and response-dose in a 12-month clozapine trial. American Journal of Psychiatry, 154, 1243–7.
Conrad, K. (1958). Die Beginnende Schizophrenie. Stuttgart: Georg Thieme.
Conus, P. & McGorry, P. D. (2002). First episode mania: a neglected priority for early intervention. Australian and New Zealand Journal of Psychiatry, 36, 158–72.
Conus, P. & McGorry, P. D. (2002). First-episode mania: a neglected priority for early intervention. Australian and New Zealand Journal of Psychiatry, 36, 158–72.
Conus, P., Abdel-Baki, A., Harrigan, S., Lambert, M. & McGorry, P. D. (2004). Schneiderian first rank symptoms predict poor outcome within first episode manic psychosis. Journal of Affective Disorders, 81, 259–68.
Conus, P., Abdel-Baki, A., Harrigan, S., Lambert, M. & McGorry, P. D. (2004). Schneiderian first rank symptoms predict poor outcome within first episode manic psychosis. Journal of Affective Disorders, 81, 259–68.
Conus, P., Berk, M. & McGorry, P. D. (2006b). Pharmacological treatment in the early phase of bipolar disorders: what stage are we at? Australian and New Zealand Journal of Psychiatry, 40, 199–207.
Conus, P., Berk, M., Hallam, K., Lucas, N. & Ward, J. (2006c). The prodrome to first episode psychotic mania: results of a retrospective study. Schizophrenia Research, 86(Suppl), 37.
Conus, P., Cotton, S., Abdel-Baki, A. & McGorry, P. D. (2006a). Symptomatic and functional outcome 12 months after a first episode of psychotic mania: barriers to recovery in a catchment area sample. Bipolar Disorders, 8, 221–31.
Cook, J. A., Leff, H. S., Blyler, C. R. et al. (2005). Results of a multisite randomized trial of supported employment interventions for individuals with severe mental illness. Archives of General Psychiatry, 62, 505–12.
Cook, J. A., Pickett, S. A., Razzano, L. et al. (1996). Rehabilitation services for persons with schizophrenia. Psychiatric Annals, 26, 97–104.
Coppen, A. (1994). Depression as a lethal disease: prevention strategies. Journal of Clinical Psychiatry, 55(Suppl), 37–45.
Corcoran, C., Malaspina, D. & Hercher, L. (2005). Prodromal interventions for schizophrenia vulnerability: the risks of being ‘at risk’. Schizophrenia Research, 73, 173–84.
Corcoran, C., Malaspina, D. & Hercher, L. (2005). Prodromal interventions for schizophrenia vulnerability: the risks of being ‘at risk’. Schizophrenia Research, 73, 173–84.
Cornblatt, B. A. & Keilp, J. G. (1994). Impaired attention, genetics, and the pathophysiology of schizophrenia. Schizophrenia Bulletin, 20, 31–46.
Cornblatt, B. A. (2002). The New York High Risk Project to the Hillside Recognition and Prevention (RAP) program. American Journal of Medical Genetics, 114, 956–66.
Cornblatt, B. A., Lencz, T. & Kane, J. M. (2001). Treatment of the schizophrenia prodrome: is it presently ethical? Schizophrenia Research, 51, 31–8.
Cornblatt, B. A., Lencz, T. & Kane, J. M. (2001). Treatment of the schizophrenia prodrome: it is presently ethical? Schizophrenia Research, 51, 31–8.
Cornblatt, B. A., Lencz, T., Correll, C., Auther, A. & Smith, C. (2002). Treating the prodrome: naturalistic findings from the RAP program. Acta Psychiatrica Scandinavica, 106, 44.
Cornblatt, B. A., Lencz, T., Smith, C. W. et al. (2003). The schizophrenia prodrome revisited: a neurodevelopmental perspective. Schizophrenia Bulletin, 29, 633–51.
Cornwall, P. L. & Scott, J. (1996). Burden of care, psychological distress and satisfaction with services in the relatives of acutely mentally disordered adults. Social Psychiatry and Psychiatric Epidemiology, 31, 345–8.
Correll, C. U., Leucht, S. & Kane, J. M. (2004). Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies. American Journal of Psychiatry, 161, 414–25.
Corrigan, P. W. & Watson, A. C. (2002). The paradox of self-stigma and mental illness. Clinical Psychology, Science and Practice, 9, 35–53.
Coryell, W., Scheftner, W., Keller, M. et al. (1993). The enduring psychosocial consequences of mania and depression. American Journal of Psychiatry, 150, 720–7.
Cossof, S. J. & Häfner, R. J., (1998). The prevalence of comorbid anxiety in schizophrenia, schizoaffective disorder and bipolar disorder. Australian and New Zealand Journal of Psychiatry, 32, 67–72.
Cosway, R., Byrne, M., Clafferty, R. et al. (2000). Neuropsychological change in young people at high risk for schizophrenia: results from the first two neuropsychological assessments of the Edinburgh High Risk Study. Psychological Medicine, 30, 1111–21.
Cosway, R., Byrne, M., Clafferty, R. et al. (2002). Sustained attention in young people at high risk for schizophrenia. Psychological Medicine, 32, 277–86.
Cougnard, A., Kalmi, E., Desage, A. et al. (2004a). Pathways to care of first-admitted subjects with psychosis in South-Western France. Psychological Medicine, 34, 267–76.
Cougnard, A., Kalmi, E., Desage, A. et al. (2004b). Factors influencing compulsory admission in first episode subjects with psychosis. Social Psychiatry and Psychiatric Epidemiology, 39, 804–9.
Coyne, J. C., Wortman, C. B. & Lehman, D. R. (1988). The other side of support: emotional overinvolvement and miscarried helping. In B. H. Gottlieb (eds.), Marshalling Social Support: Formats, Processes, and Effects. Thousand Oaks, CA: Sage, pp. 305–30.
Craddock, N., O'Donovan, M. C. & Owen, M. J. (2006). Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology. Schizophrenia Bulletin, 32, 9–16.
Craddock, N., Owen, M. J. & O'Donovan, M. C. (2006). The catechol-O-methyltransferase (COMT) gene as a candidate for psychiatric phenotypes: evidence and lessons. Molecular Psychiatry, 11, 446–58.
Craig, T. J., Grossman, S., Mojtabai, R. et al. (2004). Medication use patterns and 2-year outcome in first-admission bipolar disorders with psychotic features. Bipolar Disorders, 6, 406–15.
Craig, T. J., Ye, Q. & Bromet, E. J. (2006). Mortality among first-admission patients with psychosis. Comprehensive Psychiatry, 47, 246–51.
Craig, T. K. J., Garety, P., Power, P. et al. (2004). The Lambeth Early Onset (LEO) team: randomised controlled trial of the effectiveness of specialised care for early psychosis. British Medical Journal, 329, 1067–8.
Craig, T., Bromet, E. J., Fennig, S., Tanenberg-Karant, M., Lavelle, J. & Galambos, N. (2000). Is there an association between duration of untreated psychosis and 24-month clinical outcome in a first-admission series? American Journal of Psychiatry, 157, 60–6.
Craig, T., Fennig, S., Tanenberg-Karant, M. & Bromet, E. J. (1999). Six-month clinical status as a predictor of 24-month clinical outcome in first-admission patients with schizophrenia. Annals of Clinical Psychiatry, 11, 197–203.
Craig, T., Garety, P., Power, P. et al. (2004). Lambeth Early Onset Service: a randomised controlled trial. Schizophrenia Research, 70(Suppl), 145–6.
Cramer, J. A. & Rosenheck, R. (1998). Compliance with medication regimens for mental and physical disorders. Psychiatric Services, 49, 196–201.
Crow, T. J., Macmillan, J. F., Johnston, A. L. & Johnstone, E. C. (1986). The Northwick Park study of first episodes of schizophrenia II. A randomized controlled trial of prophylactic neuroleptic treatment. British Journal of Psychiatry, 148, 120–7.
Crown, W. H., Finkelstein, S., Berndt, E. R. et al. (2002). The impact of treatment-resistant depression on healthcare utilization and costs. Journal of Clinical Psychiatry, 63, 963–71.
Crowther, R. E. & Marshall, M. (2001). Employment rehabilitation schemes for people with mental health problems in the North West region: service characteristics and utilisation. Journal of Mental Health, 10, 373–81.
Crowther, R. E., Marshall, M., Bond, G. R. & Huxley, P. (2001). Helping people with severe mental illness to obtain work: systematic review. British Medical Journal, 322, 204–8.
Csernansky, J. G., Mahmoud, R. & Brenner, R. (2002). A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia. New England Journal of Medicine, 346, 16–22.
Cuesta, M. J., Peralta, V., Caro, F. & Leon, J. (1995). Is poor insight in psychotic disorders associated with poor performance on the Wisconsin Card Sorting Test? American Journal of Psychiatry, 152, 1380–2.
Dahlsgaard, K. K., Beck, A. T. & Brown, G. K. (1998). Inadequate response to therapy as a predictor of suicide. Suicide and Life-Threatening Behaviour; 28, 197–204.
Danish Psychiatric Society (1998). Behandlung med antipsykotika: vejledende ratningslinier. [Guidelines for treatment with antipsychotic drugs]. Ugeskrift for Laeger, 160(Suppl 5).
Darroch, J. (1997). Biologic synergism and parallelism. [See comments.] American Journal of Epidemiology, 145, 661–8.
Daskalakis, Z. J., Christensen, B. K., Chen, R. et al. (2002). Evidence for impaired cortical inhibition in schizophrenia using transcranial magnetic stimulation. Archives of General Psychiatry, 59, 347–54.
Dassa, D., Sham, P. C., van Os, J. et al. (1996). Relationship of birth season to clinical features, family history, and obstetric complication in schizophrenia. Psychiatry Research, 64, 11–17.
David, A. S., Malmberg, A., Brandt, L., Allebeck, P. & Lewis, G. (1997). IQ and risk for schizophrenia: a population-based cohort study. Psychological Medicine, 27, 1311–23.
Davidson, J., Hughes, D., George, L. & Blazer, D. (1993). The epidemiology of social phobia: findings from the Duke Epidemiological Catchment Area Study. Psychological Medicine, 23, 709–18.
Davidson, L. L. & Heinrichs, R. W. (2003). Quantification of frontal and temporal lobe brain-imaging findings in schizophrenia: a meta-analysis. Psychiatry Research, 122, 69–87.
Davidson, M. W. & Range, L. M. (1999). Are teachers of children and young adolescents responsive to suicide prevention training modules? Yes. Death Studies, 23, 61–71.
Davidson, M., Reichenberg, A., Rabinowitz, J. et al. (1999). Behavioral and intellectual markers for schizophrenia in apparently healthy male adolescents. American Journal of Psychiatry, 156, 1328–35.
Davis, J. O. & Phelps, J. A. (1995). Twins with schizophrenia: genes or germs? Schizophrenia Bulletin, 21, 13–18.
Davis, K. L., Buchsbaum, M. S., Shihabuddin, L. et al. (1998). Ventricular enlargement in poor-outcome schizophrenia. Biological Psychiatry, 43, 783–93.
Davis, K. L., Stewart, D. G., Friedman, J. I. et al. (2003). White matter changes in schizophrenia: evidence for myelin-related dysfunction. Archives of General Psychiatry, 60, 443–56.
Day, J. C., Bentall, R. P., Roberts, C. et al. (2005). Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals. Archives of General Psychiatry, 62, 717–24.
Day, R., Nielsen, J. A., Korten, A. et al. (1987). Stressful life events preceding the acute onset of schizophrenia: a cross-national study from the World Health Organization. Culture, Medicine and Psychiatry, 11, 123–205.
de Haan, L., Linszen, D. H., Lenior, M. E., de Win, E. D. & Gorsira, R. (2003). Duration of untreated psychosis and outcome of schizophrenia: delay in intensive psychosocial treatment versus delay in treatment with antipsychotic medication. Schizophrenia Bulletin, 29, 341–8.
de Haan, L., Peters, B., Dingemans, P., Wouters, L. & Linszen, D. (2002). Attitudes of patients toward the first psychotic episode and the start of treatment. Schizophrenia Bulletin, 28, 431–42.
de Haan, L., van Nimwegen, L., van Amelsvoort, T., Dingemans, P. & Linszen, D. (2008). Improvement of subjective well-being and enduring symptomatic remission; a 5 year follow up of first episode schizophrenia. Pharmacopsychiatry, 41, 125–8.
de Haan, L., Welborn, K., Krikke, M. & Linszen, D. (2004). Opinions of mothers on the first psychotic episode and the start of treatment of their child. European Psychiatry, 19, 226–9.
de Haan, L., Welborn, K., Krikke, M. & Linszen, D. H. (2004). Opinions of mothers on the first psychotic episode and the start of treatment of their child. European Psychiatry, 19, 226–9.
de Haan, L., Welborn, K., Krikke, M. & Linszen, D. H. (2004). Opinions of mothers on the first psychotic episode and the start of treatment of their child. European Psychiatry, 19, 226–9.
De Hert, M., McKenzie, K. & Peuskens, J. (2001). Risk factors for suicide in young people suffering from schizophrenia: a long-term follow-up study. Schizophrenia Research, 47, 127–34.
de Jesus Mari, J. & Streiner, D. L. (1994). An overview of family interventions and relapse on schizophrenia: meta-analysis of research findings. Psychological Medicine, 24, 565–78.
De Luca, C. R., Wood, S. J., Anderson, V. et al. (2003). Normative data from the CANTAB. I: development of executive function over the lifespan. Journal of Clinical and Experimental Neuropsychology, 25, 242–54.
de Wilde, O. M., Bour, L. J., Dingemans, P. M., Koelman, J. H. & Linszen, D. H. (2007). Failure to find p50 suppression deficits in young first-episode patients with schizophrenia and clinically unaffected siblings. Schizophrenia Bulletin, 33, 1319–23.
Deegan, P. E. (1988). Recovery: the lived experience of rehabilitation. Psychosocial Rehabilitation Journal, 11, 11–19.
Deffenbacher, J. L. & McKay, M. (2000). Overcoming Situational and General Anger: A Protocol for the Treatment of Anger Based on Relaxation, Cognitive Restructuring, and Coping Skills Training. Oakland, CA: New Harbinger.
Degenhardt, L. & Hall, W. (2001). The association between psychosis and problematical drug use among Australian adults: findings from the National Survey of Mental Health and Well-being. Psychological Medicine, 31, 659–68.
Degenhardt, L., Hall, W. & Lynskey, M. (2003). Testing hypotheses about the relationship between cannabis use and psychosis. Drug and Alcohol Dependence, 71, 37–48.
Delisi, L. E. (1999a). Defining the course of brain structural change and plasticity in schizophrenia. Psychiatry Research, 92, 1–9.
Delisi, L. E. (1999b). Regional brain volume change over the lifetime course of schizophrenia. Journal of Psychiatric Research, 33, 535–41.
Delisi, L. E. (1999c). Structural brain changes in schizophrenia. Archives of General Psychiatry, 56, 195–6.
DeLisi, L. E., Boccio, A. M., Riordan, H. et al. (1991). Familial thyroid disease and delayed language development in first admission patients with schizophrenia. Psychiatry Research, 38, 39–50.
Department of Health (2000). The NHS Plan. A Plan For Investment, A Plan For Reform. London: Department of Health.
Department of Health (2001a). Compendium of Clinical and Social Indicators. London: The Stationery Office.
Department of Health (2001b). The Mental Health Policy Implementation Guide. London: The Stationery Office.
Dervaux, A., Bayle, F. J., Laqueille, X. et al. (2001). Is substance abuse in schizophrenia related to impulsivity, sensation seeking, or anhedonia? American Journal of Psychiatry, 158, 492–4.
Desai, R. A., Dausey, D. J., Rosenhack, R. A. (2005). Mental health service delivery and suicide risk: the role of individual patient and facility factors. American Journal of Psychiatry, 162, 311–18.
Detera-Wadleigh, S. D. & McMahon, F. J. (2006). G72/G30 in schizophrenia and bipolar disorder: review and meta-analysis. Biological Psychiatry, 60, 106–14.
Dickinson, D., Ramsey, M. E. & Gold, J. M. (2007). Overlooking the obvious: a meta-analytic comparison of digit symbol coding tasks and other cognitive measures in schizophrenia. Archives of General Psychiatry, 64, 532–42.
Dingemans, P. M. A. J., Lenior, M. E. & Linszen, D. H. (1998). Personality and schizophrenia relapse. International Clinical Psychopharmacology, 13(Suppl 1), 89–95.
Dingemans, P. M. A. J., Lenior, M. E. & Linszen, D. H. (1998). Personality and schizophrenia relapse. International Clinical Psychopharmacology, 13(Suppl 1), S89–95.
Dingemans, P. M., Linszen, D. H. & Lenior, M. (2002). Patient psychopathology and parental expressed emotion in schizophrenia revisited. In A. Schaub (eds.), New Family Interventions and Associated Research in Psychiatric Disorders. New York: Springer-Verlag, pp. 91–8.
Dion, G. L., Tohen, M., Anthony, W. A. & Waternaux, C. S. (1988). Symptoms and functioning of patients with bipolar disorder six months after hospitalisation. Hospital and Community Psychiatry, 39, 652–7.
Dixon, L. B. & Lehman, A. F. (1995). Family interventions for schizophrenia. Schizophrenia Bulletin, 21, 631–43.
Dixon, L., Haas, G., Weiden, P. J., Sweeney, J. & Frances, A. J. (1991). Drug abuse in schizophrenic patients: clinical correlates and reasons for use. American Journal of Psychiatry, 148, 224–30.
Dixon, L., Lucksted, A., Stewart, B. et al. (2004). Outcomes of the peer-taught 12-week family-to-family education programme for severe mental illness. Acta Psychiatrica Scandinavica, 109, 207–15.
Dixon, L., McFarlane, W. R., Lefley, H. et al. (2001). Evidence-based practices for services to families of people with psychiatric disabilities. Psychiatric Services, 52, 903–10.
Dixon, L., McNary, S. & Lehman, A. (1995). Substance abuse and family relationships of persons with severe mental illness. American Journal of Psychiatry, 152, 456–8.
Docherty, J. P., van Kammen, D. P., Siris, S. G. & Marder, S. R. (1978). Stages of onset of schizophrenic psychosis. American Journal of Psychiatry, 135, 420–6.
Doka, K. J. (1989). Disenfranchised Grief: Recognizing Hidden Sorrow. Lexington, MA: Lexington Books.
Donlon, P. T. & Blacker, K. H. (1973). Stages of schizophrenic decompensation and reintegration. Journal of Nervous and Mental Disease, 157, 200–9.
Drake, R. E., Gates, C., Cotton, P. G. & Whitaker, A. (1984). Suicide among schizophrenics: who is at risk? Journal of Nervous and Mental Disease, 172, 613–17.
Drake, R. E., McHugo, G. J., Becker, D. R., Anthony, W. A. & Clark, R. E. (1996). The New Hampshire study of supported employment for people with severe mental illness. Journal of Consulting and Clinical Psychology, 64, 391–9.
Drake, R. E., McHugo, G. J., Xie, H. et al. (2006). Ten-year recovery outcomes for clients with co-occurring schizophrenia and substance use disorders. Schizophrenia Bulletin, 32, 464–73.
Drake, R. E., McHugo, G., Bebout, R. R. et al. (1999). A randomized clinical trial of supported employment for inner-city patients with severe mental illness. Archives of General Psychiatry, 56, 627–33.
Drake, R. E., Mercer-McFadden, C., Mueser, K. T., McHugo, G. J. & Bond, G. R. (1998). Review of integrated mental health and substance-abuse treatment for patients with dual disorders. Schizophrenia Bulletin, 24, 589–608.
Drake, R. E., Mueser, K. T., Brunette, M. F. & McHugo, G. J. (2004). A review of treatments for people with severe mental illnesses and co-occurring substance use disorders. Psychiatric Rehabilitation Journal, 27, 360–74.
Drake, R. J., Haley, C. J., Akhtar, S. & Lewis, S. W. (2000). Causes and consequences of duration of untreated psychosis in schizophrenia. British Journal of Psychiatry, 177, 511–15.
Drake, R. J., Haley, C. J., Akhtar, S. & Lewis, S. W. (2000). Causes and consequences of duration of untreated psychosis in schizophrenia. British Journal of Psychiatry, 177, 511–15.
Drake, R., Becker, D. & Bond, G. (2003). Recent research on vocational rehabilitation for persons with severe mental illness. Current Opinion in Psychiatry, 16, 451–5.
Drury, V., Birchwood, M., Cochrane, R. & MacMillan, F. (1996). Cognitive therapy and recovery from acute psychosis: a controlled trial: I. Impact on psychotic symptoms. British Journal of Psychiatry, 169, 593–601.
Ducci, G., Stentella, C. & Vulterini, P. (2002). The social enterprise in Europe: the state of the art. International Journal of Mental Health, 31, 76–91.
Dupuy, H. J. (1984). The psychological general well-being (PGWB) index. In N. K. Wenger, M. E. Mattson, C. D. Furberg & J. Elinson (eds.), Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies. New York: Le Jacq, pp. 170–83.
Early Psychosis Prevention and Intervention Centre (EPPIC) (2000). Early Psychosis Manuals, 3: Working with Groups in Early Psychosis. Melbourne, Australia: Psychiatric Services Branch, Victoria Health Service.
Eaton, W. W. (2001). The Sociology of Mental Disorders, 3rd edn. Westport, CT: Praeger.
Eder-Ischia, U., Ebenbichler, C. & Fleischhacker, W. W. (2005). Olanzapine-induced weight gain and disturbances of lipid and glucose metabolism. Essential Psychopharmacology, 6, 112–17.
Edwards, E., Elkins, K., Hinton, M. et al. (2006). Randomized controlled trial of a cannabis-focused intervention for young people with first-episode psychosis. Acta Psychiatrica Scandinavica, 114, 109–17.
Edwards, J. & McGorry, P. (2002). Implementing Early Intervention in Psychosis. London: Martin Dunitz.
Edwards, J. & McGorry, P. D. (2002). Implementing Early Intervention in Psychosis: A Guide to Establishing Early Psychosis Services. London: Martin Dunitz.
Edwards, J. & McGorry, P. D. (2002). Implementing Early Intervention in Psychosis: A Guide to Establishing Early Psychosis Services. London: Martin Dunitz.
Edwards, J. & McGorry, P. D. (2002). Implementing Early Intervention in Psychosis: A Guide to Establishing Early Psychosis Services. London: Martin Dunitz.
Edwards, J. & McGorry, P. D. (2002). Multi-component early intervention: models of good practice. In J. Edwards & P. D. McGorry (eds.), Implementing Early Intervention in Psychosis. London: Martin Dunitz, pp. 63–84.
Edwards, J., Elkins, K., Hinton, M. et al. (2006). Randomized controlled trial of a cannabis-focused intervention for young people with first-episode psychosis. Acta Psychiatrica Scandinavica, 114, 109–17.
Edwards, J., Francey, S. M., McGorry, P. D. & Jackson, H. J. (1994). Early psychosis prevention and intervention: evolution of a comprehensive community-based specialised service. Behaviour Change. Special Issue: Behaviour Therapy and Schizophrenia I, 11, 223–33.
Edwards, J., Francey, S. M., McGorry, P. D. & Jackson, H. J. (1996). Early psychosis prevention and intervention: evolution of a comprehensive community-based specialized service. Behavior Change, 11, 223–33.
Edwards, J., Harris, M. & Herman, A. (2002b). The Early Psychosis Prevention and Intervention Centre, Melbourne, Australia: an overview, November 2001. In C. Ogura (ed.), Recent Advances in Early Intervention and Prevention in Psychiatric Disorders. Tokyo: Seiwa Shoten, pp. 26–33.
Edwards, J., Harris, M. G. & Bapat, S. (2005). Developing services for first episode psychosis and the critical period. British Journal of Psychiatry, 187(Suppl 48), s91–7.
Edwards, J., Harris, M. G. & Bapat, S. (2005). Developing services for first episode psychosis and the critical period. British Journal of Psychiatry, 187(Suppl 48), s91–7.
Edwards, J., Hinton, M., Elkins, K. & Athanasopolous, O. (2003). Cannabis abuse and first-episode psychosis. In H. L. Graham, A. Copello, M. Birchwood & K. T. Mueser (eds.), Substance Misuse in Psychosis: Approaches to Treatment and Service Delivery. Chichester, UK: John Wiley, pp. 283–304.
Edwards, J., Hinton, M., Elkins, K. & Athanasopoulos, O. (2003). Cannabis and first-episode psychosis: the CAP project. In H. L. Graham, A. Copello, M. J. Birchwood & K. T. Mueser (eds.), Substance Misuse in Psychosis: Approaches to Treatment and Service Delivery. Chichester, UK: John Wiley, pp. 283–304.
Edwards, J., Maude, D., Herrmann-Doig, T. et al. (2002a). A service response to prolonged recovery in early psychosis. Psychiatric Services, 53, 1067–9.
Edwards, J., Maude, D., McGorry, P. D., Harrigan, S. M. & Cocks, J. T. (1998). Prolonged recovery in first-episode psychosis. British Journal of Psychiatry, 172(Suppl 33), s107–16.
Edwards, J., Maude, D., McGorry, P. D., Harrigan, S. M. & Cocks, J. T. (1998). Prolonged recovery in first-episode psychosis. British Journal of Psychiatry, 172(Suppl), s107–16.
Edwards, J., McGorry, P., Waddell, F. & Harrigan, S. (1999). Enduring negative symptoms in first-episode psychosis: comparison of six methods using follow-up data. Schizophrenia Research, 40, 147–58.
Egan, M. F., Goldberg, T. E., Gscheidle, T. et al. (2001b). Relative risk for cognitive impairments in siblings of patients with schizophrenia. Biological Psychiatry, 50, 98–107.
Egan, M. F., Goldberg, T. E., Kolachana, B. S. et al. (2001). Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proceedings of the National Academy of Sciences, USA, 98, 6917–22.
Egan, M. F., Goldberg, T. E., Kolachana, B. S. et al. (2001a). Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proceedings of the National Academy of Sciences USA, 98, 6917–22.
Egan, M. F., Kojima, M., Callicott, J. H. et al. (2003). The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell, 112, 257–69.
Egan, M. F., Straub, R. E., Goldberg, T. E. et al. (2004). Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia. Proceedings of the National Academy of Sciences USA, 101, 12604–9.
Egeland, J. A., Blumenthal, R. L., Nee, J., Sharpe, L. & Eddincott, J. (1987). Reliability and relationship of various ages of onset criteria for major affective disorders. Journal of Affective Disorders, 12, 159–65.
Egeland, J. A., Hostetter, A. M., Pauls, D. L. & Sussex, J. N. (2000). Prodromal symptoms before onset of manic–depressive disorder suggested by first hospital admission histories. Journal of the American Academy of Child and Adolescent Psychiatry, 39, 1245–52.
Ekelund, J., Hovatta, I., Parker, A. et al. (2001). Chromosome 1 loci in Finnish schizophrenia families. Human Molecular Genetics, 10, 1611–17.
Elkins, K., Hinton, M. & Edwards, J. (2004). Cannabis and psychosis: a psychological intervention. In J. F. M. Gleeson & P. D. McGorry (eds.), Psychological Interventions in Early Psychosis. Chichester, UK: John Wiley, pp. 137–56.
Ellis, T. E. & Newman, C. F. (1996). Choosing to Live. Oakland, CA: New Harbinger.
Emsley, R. A. (1999). Risperidone in the treatment of first-episode psychotic patients: a double-blind multicenter study. Risperidone Working Group. Schizophrenia Bulletin, 25, 721–9.
Emsley, R. A., Rabinowitz, J. & Medori, R. (2006). Time course for antipsychotic treatment response in first-episode schizophrenia. American Journal of Psychiatry, 163, 743–5.
Emsley, R., Oostihuizen, P., Joubert, A., Roberts, M. & Stein, D. J. (1999). Depressive and anxiety symptoms in patients with schizophrenia and schizophreniform disorder. Journal of Clinical Psychiatry, 60, 747–51.
Emsley, R., Rabinowitz, J. & Medori, R. (2006). Time course for antipsychotic treatment response in first-episode schizophrenia. American Journal of Psychiatry, 163, 743–5.
EPPIC (1997). Early Psychosis Training Pack. Melbourne: Early Psychosis Prevention and Intervention Centre.
EPPIC (2001). Case Management in Early Psychosis: A Handbook. Melbourne: Early Psychosis Prevention and Intervention Centre.
EPPIC and the Victorian Department of Human Services (1997). Working with Families in Early Psychosis. Melbourne: Early Psychosis Prevention and Intervention Centre Statewide Services.
Erikson, D. H., Beiser, M. & Iacono, W. G. (1998). Social support predicts 5-year outcome in first-episode schizophrenia. Journal of Abnormal Psychology, 107, 681–5.
Erikson, D. H., Beiser, M., Iacono, W. G., Fleming, J. A. & Lin, T. (1989). The role of social relationships in the course of first-episode schizophrenia and affective psychosis. American Journal of Psychiatry, 146, 1456–61.
Erlenmeyer-Kimling, L., Rock, D., Roberts, S. A. et al. (2000). Attention, memory, and motor skills as childhood predictors of schizophrenia-related psychoses: the New York High-risk Project. American Journal of Psychiatry, 157, 1416–22.
Ernst, C. L. & Goldberg, J. F. (2004). Clinical features related to age at onset in bipolar disorder. Journal of Affective Disorders, 82, 21–7.
Escher, S., Romme, M., Buiks, A., Delespaul, P. & van Os, J. (2002). Formation of delusional ideation in adolescents hearing voices: a prospective study. American Journal of Medical Genetics, 114, 913–20.
Etheridge, K., Yarrow, L. & Peet, M. (2004). Pathways to care in first episode psychosis. Journal of Psychiatric and Mental Health Nursing, 11, 125–8.
Ettinger, U., Picchioni, M., Hall, M. H. et al. (2006). Antisaccade performance in monozygotic twins discordant for schizophrenia: the Maudsley twin study. American Journal of Psychiatry, 163, 543–5.
Evans, E., Hawton, K., Rodham, K. & Deeks, J. (2005). The prevalence of suicidal phenomena in adolescents: a systematic review of population-based studies. Suicide and Life-Threatening Behaviour, 35, 239–50.
Evins, A. E., Mays, V. K., Rigotti, N. A. et al. (2001). A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia. Nicotine and Tobacco Research, 3, 397–403.
Fadden, G. I. (1997). Implementation of family interventions in routine clinical practice following staff training programs: a major cause for concern. Journal of Mental Health, 6, 599–612.
Fadden, G. I. (1998). Family intervention in psychosis. Journal of Mental Health, 7, 115–22.
Falloon, I. R. & Lillie, F. J. (1988). Behavioral family therapy: an overview. In I. R. Falloon (ed.), Handbook of Behavioral Family Therapy. New York: Guilford Press, pp. 3–26.
Falloon, I. R. (1983). Relapse in schizophrenia: a review of the concept and its definitions. Psychological Medicine, 13, 469–77.
Falloon, I. R. H. (1992). Early intervention for first episodes of schizophrenia: a preliminary exploration. Psychiatry, 55, 4–15.
Falloon, I. R. H., Boyd, J. L., McGill, C. W. et al. (1985). Family management in the prevention of morbidity of schizophrenia. Archives of General Psychiatry, 42, 887–96.
Falls, D. L. (2003). Neuregulins: functions, forms, and signaling strategies. Experimental Cell Research, 284, 14–30.
Falzer, P. R., Stayner, D. A. & Davidson, L. (2004). Principles and strategies for developing psychosocial treatments for negative symptoms in early course psychosis. In J. F. M. Gleeson & P. D. McGorry (eds.), Psychological Interventions in Early Psychosis. Chichester, UK: John Wiley, pp. 229–43.
Faulkner, G., Soundy, A. A. & Lloyd, K. (2003). Schizophrenia and weight management: a systematic review of interventions to control weight. Acta Psychiatrica Scandinavica, 108, 324–32.
Faux, S. F., McCarley, R. W., Nestor, P. G. et al. (1993). P300 topographic asymmetries are present in unmedicated schizophrenics. Electroencephalography and Clinical Neurophysiology, 88, 32–41.
Fava, G. A. & Kellner, R. (1993). Staging: a neglected dimension in psychiatric classification. Acta Psychiatrica Scandinavica, 87, 225–30.
Fava, M. (2001). Augmentation and combination strategies in treatment-resistant depression. Journal of Clinical Psychiatry, 62(Suppl 18), 4–11.
Fava, M. (2003). Diagnosis and definition of treatment-resistant depression. Biological Psychiatry, 53, 649–59.
Fearon, M., Donaldson, C., Burns, A. & Tarrier, N. (1998). Intimacy as a determinant of expressed emotion in carers of people with Alzheimer's disease. Psychological Medicine, 28, 1085–90.
Fearon, P., Kirkbride, J., Morgan, C. et al. (2006). Incidence of schizophrenia and other psychoses in ethnic minority groups: results from MRC AESOP study. Psychological Medicine, 36, 1541–50.
Feinberg, I. (1982). Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence? Journal of Psychiatric Research, 17, 319–34.
Fenigstein, A., Scheier, M. F. & Buss, A. H. (1975). Public and private self-consciousness. Assessment and theory. Journal of Consulting and Clinical Psychology, 43, 522–7.
Fennig, S., Horesh, N., Aloni, D., Apter, A., Weizman, A. & Fennig, S. (2005). Life events and suicidality in adolescents with schizophrenia. European Child and Adolescent Psychiatry, 14, 454–460.
Fenton, W. & McGlashan, T. (1991). Natural history of schizophrenia subtypes. Archives of General Psychiatry, 48, 969–77.
Fenton, W. S. & McGlashan, T. H. (1989). Risk of schizophrenia in character disordered patients. American Journal of Psychiatry, 146, 1280–4.
Fenton, W. S., Mosher, L. R., Herrell, J. M. & Blyler, C. R. (1998). Randomized trial of general hospital and residential alternative care for patients with severe and persistent mental illness. American Journal of Psychiatry, 155, 516–22.
Fenwick, C. D., Vassilas, C. A., Carter, H. & Haque, M. S. (2004). Training health professionals in the recognition, assessment and management of suicide risk. International Journal of Psychiatry in Clinical Practice, 8, 117–21.
Fergusson, D. M., Horwood, L. J. & Swain-Campbell, N. R. (2003). Cannabis dependence and psychotic symptoms in young people. Psychological Medicine, 33, 15–21.
Fergusson, D. M., Poulton, R., Smith, P. F. & Boden, J. M. (2006). Cannabis and psychosis. British Medical Journal, 332, 172–5.
First, M. B., Spitzer, R. L., Gibbon, M. & Williams, J. B. W. (2002). Structured Clinical Interview for DSM-IV-TR Axis I Disorders, research version, patient edn (SCID-I/P). New York: Biometrics Research, New York State Psychiatric Institute.
Fischer, M. (1971). Psychoses in the offspring of schizophrenic monozygotic twins and their normal co-twins. British Journal of Psychiatry, 118, 43–52.
Fischer, W., Goerg, D., Zbinden, E. & Guimon, J. (1999). Determining factors and the effects of attitudes towards psychotropic medication. In J. Guimon, W. Fischer & N. Sartorius (eds.), The Image of Madness: The Public Facing Mental Illness and Psychiatric Treatment. Basel: Karger, pp. 162–86.
Fitzgerald, P. B. (2001). The role of early warning symptoms in the detection and prevention of relapse in schizophrenia. Australian and New Zealand Journal of Psychiatry, 35, 758–64.
Fitzgerald, P. B., Benitez, J., Daskalakis, J. Z. et al. (2005). A double-blind sham-controlled trial of repetitive transcranial magnetic stimulation in the treatment of refractory auditory hallucinations. Journal of Clinical Psychopharmacology, 25, 358–62.
Flint, J. (1992). Implications of genomic imprinting for psychiatric genetics. Psychological Medicine, 22, 5–10.
Flyckt, L., Mattsson, M., Edman, G., Carlsson, R. & Cullberg, J. (2006). Predicting 5-year outcome in first-episode psychosis: construction of a prognostic rating scale. Journal of Clinical Psychiatry, 67, 916–24.
Flyckt, L., Mattsson, M., Edman, G., Carlsson, R. & Cullberg, J. (2006). Predicting 5-year outcome in first-episode psychosis: construction of a prognostic rating scale. Journal of Clinical Psychiatry, 67, 916–24.
Fombonne, E., Wostear, G., Cooper, V., Harrington, R. & Rutter, M. (2001). The Maudsley long-term follow-up of child and adolescent depression. 1. Psychiatric outcomes in adulthood. British Journal of Psychiatry, 179, 210–17.
Ford, J. M., White, P. M., Csernansky, J. G. et al. (1994). ERPs in schizophrenia: effects of antipsychotic medication. Biological Psychiatry, 36, 153–70.
Fornito, A., Yücel, M., Wood, S. J. et al. (2006). Morphology of the paracingulate sulcus and executive cognition in schizophrenia. Schizophrenia Research, 88, 192–7.
Fornito, A., Yücel, M., Wood, S. J. et al. (2008). Surface-based morphometry of the anterior cingulate cortex in first episode schizophrenia. Human Brain Mapping, 29, 478–89.
Fountoulakis, K. N., Nimatoudis, I., Iacovides, A. & Kaprinis, G. (2004). Off-label indications for atypical antipsychotics: a systematic review. Annual General Hospital Psychiatry, 3, 1–10.
Fowler, D., Garety, P. & Kuipers, E. (1995). Cognitive Behavior Therapy for Psychosis. Chichester, UK: John Wiley.
Fowler, D., Garety, P. & Kuipers, E. (1995). Cognitive Behaviour Therapy for Psychosis: Theory and Practice. Chichester, UK: John Wiley.
Fraga, M. F., Ballestar, E., Paz, M. F. et al. (2005). Epigenetic differences arise during the lifetime of monozygotic twins. Proceedings of the National Academy of Sciences USA, 102, 10604–9.
Francey, S. M., Jackson, H. J., Phillips, L. J. et al. (2005). Sustained attention in young people at high risk of psychosis does not predict transition to psychosis. Schizophrenia Research, 79, 127–36.
Francey, S. M., Jackson, H. J., Phillips, L. J. et al. (2005). Sustained attention in young people at high risk of psychosis does not predict transition to psychosis. Schizophrenia Research, 79, 127–36.
Francey, S. M., Jovev, M., Phassouliotis, C. et al. (2006). Co-morbid borderline personality disorder and first episode psychosis: how many and what happens? Schizophrenia Research, 86(Suppl), 113.
Francis, A. & Papageorgiou, P. (2004). Expressed emotion in Greek versus Anglo-Saxon families of individuals with schizophrenia. Australian Psychologist, 39, 172–7.
Frangou, S., Sharma, T., Alarcon, G. et al. (1997). The Maudsley Family Study, II: Endogenous event-related potentials in familial schizophrenia. Schizophrenia Research, 23, 45–53.
Frank, E., Swartz, H. A., Mallinger, A. G. et al. (1999). Adjunctive psychotherapy for bipolar disorder: effects of changing treatment modality. Journal of Abnormal Psychology, 108, 579–87.
Freedman, R., Adams, C. E., Adler, L. E. et al. (2000). Inhibitory neurophysiological deficit as a phenotype for genetic investigation of schizophrenia. American Journal of Medical Genetics, 97, 58–64.
Freeman, A. & Reinecke, M. A. (1993). Cognitive Therapy of Suicide Behaviour: A Manual for Treatment. New York: Springer.
Freeman, D. & Garety, P. (2003). Connecting neurosis and psychosis: the direct influence of emotion on delusions and hallucinations. Behaviour Research and Therapy, 41, 923–47.
Freeman, D. & Garety, P. A. (2003). Connecting neurosis and psychosis: the direct influence of emotion on delusions and hallucinations. Behaviour Research and Therapy, 41, 923–47.
Freeman, D., Garety, P. & Phillips, M. L. (2000). An examination of hypervigilance for external threat in individuals with generalized anxiety disorder and individuals with persecutory delusions using visual scan paths. Quarterly Journal of Experimental Psychology, 53A, 549–67.
Freeman, D., Garety, P. A. & Kuipers (2001). Persecutory delusions: developing and understanding of belief and maintenance of emotional distress. Psychological Medicine, 31, 1293–306.
French, P. & Morrison, A. P. (2004). Early Detection and Cognitive Therapy for People at High Risk of Developing Psychosis: A Treatment Approach. New York: John Wiley.
Fresan, A., Apiquian, R., Ulloa, R. E. et al. (2003). Premorbid functioning by gender and its relationship with duration of untreated psychosis in first psychotic episode. Actas Españolas de Psiquiatría, 31, 53–8.
Friedman, D. & Squires-Wheeler, E. (1994). Event-related potentials (ERPs) as indicators of risk for schizophrenia. Schizophrenia Bulletin, 20, 63–74.
Friis, S., Melle, I., Larsen, T. K. et al. (2004). Does duration of untreated psychosis bias study samples of first-episode psychosis? Acta Psychiatrica Scandinavica, 110, 286–91.
Friis, S., Vaglum, P., Haahr, U. et al. (2005). Effect of an early detection programme on duration of untreated psychosis: part of the Scandinavian TIPS study. British Journal of Psychiatry, 187(Suppl 48), s29–32.
Frith, C. D. (1979). Consciousness, information processing and schizophrenia. British Journal of Psychiatry, 34, 225–35.
Fromm-Reichmann, F. (1950). Principles of Intensive Psychotherapy. Chicago, IL: University of Chicago Press.
Fuchs, J. & Steinert, T. (2004). Duration of untreated psychosis (DUP): a useful predictor of outcome in schizophrenia? Fortschritte der Neurologie-Psychiatrie, 72, 79–87.
Fuchs, J. & Steinert, T. (2004). Patients with a first episode of schizophrenia spectrum psychosis and their pathways to psychiatric hospital care in South Germany. Social Psychiatry and Psychiatric Epidemiology, 39, 375–80.
Funke, B., Malhotra, A. K., Finn, C. T. et al. (2005). COMT genetic variation confers risk for psychotic and affective disorders: a case control study. Behavioral and Brain Functions, 1, 19–27.
Furnham, A. & Chan, E. (2004). Lay theories of schizophrenia: a cross-cultural comparison of British and Hong Kong Chinese attitudes, attributions and beliefs. Social Psychiatry and Psychiatric Epidemiology, 39, 543–52.
Fusar-Poli, P., Broome, M. R., Matthiasson, P. et al. (2007b). Effects of acute antipsychotic treatment on brain activation in first episode psychosis: an fMRI study. European Neuropsychopharmacology, 17, 492–500.
Fusar-Poli, P., Perez, J., Broome, M. et al. (2007a). Neurofunctional correlates of vulnerability to psychosis: a systematic review and meta-analysis. Neurosciences and Biobehavioral Reviews, 31, 465–84.
Gaebel, W., Jaenner, M., Frommann, N. et al. (2002). First vs multiple episode schizophrenia: two-year outcome of intermittent and maintenance medication strategies. Schizophrenia Research, 53, 145–59.
Gallinat, J., Bajbouj, M., Sander, T. et al. (2003). Association of the G1947A COMT (Val(108/158)Met) gene polymorphism with prefrontal P300 during information processing. Biological Psychiatry, 54, 40–8.
Gallo, J. J., Ford, S. M. & Anthony, J. C. (1995). Filters on the pathway to mental healthcare, II. Sociodemographic factors. Psychological Medicine, 25, 1149–60.
Garety, P. A. & Rigg, A. (2001). Early psychosis in the inner city: a survey to inform service planning. Social Psychiatry and Psychiatric Epidemiology, 36, 1–8.
Garety, P. A. & Rigg, A. (2001). Early psychosis in the inner city: a survey to inform service planning. Social Psychiatry and Psychiatric Epidemiology, 36, 537–44.
Garety, P. A., Craig, T. K. J., Dunn, G. et al. (2006). Specialised care for early psychosis: symptoms, social functioning and patient satisfaction. British Journal of Psychiatry, 188, 37–45.
Garety, P. A., Craig, T. K., Dunn, G. et al. (2006). Specialised care for early psychosis: symptoms, social functioning and patient satisfaction: randomised controlled trial. British Journal of Psychiatry, 188, 37–45.
Garety, P. A., Fowler, D. & Kuipers, E. (2000). Cognitive-behavioral therapy for medication-resistant symptoms. Schizophrenia Bulletin, 26, 73–86.
Garety, P. A., Hemsley, D. R. & Wessely, S. (1991). Reasoning in deluded schizophrenic and paranoid patients: biases in performance on a probabilistic inference task. Journal of Nervous and Mental Disease, 179, 194–201.
Garety, P. A., Kuipers, E., Fowler, D., Freeman, D. & Bebbington, P. E. (2001). A cognitive model of the positive symptoms of psychosis. Psychological Medicine, 31, 189–95.
Garner, B., Pariante, C. M., Wood, S. J. et al. (2005). Pituitary volume predicts future transition to psychosis in individuals at ultra-high risk of developing psychosis. Biological Psychiatry, 58, 417–23.
Garner, B., Pariante, C. M., Wood, S. J. et al. (2005). Pituitary volume predicts future transition to psychosis in individuals at ultra-high risk of developing psychosis. Biological Psychiatry, 58, 417–23.
Gater, R. & Goldberg, D. (1991). Pathways to psychiatric care in Manchester. British Journal of Psychiatry, 159, 90–6.
Gearon, J. S. & Bellack, A. S. (1999). Women with schizophrenia and co-occurring substance use disorders: an increased risk for violent victimization and HIV. Community Mental Health Journal, 35, 401–19.
Geller, B., Tillman, R., Craney, J. L. & Bolhofner, K. (2004). Four-year prospective outcome and natural history of mania in children with a prepubertal and early adolescent bipolar disorder phenotype. Archives of General Psychiatry, 61, 459–67.
George, T. P., Vessicchio, J. C., Termine, A. et al. (2002). A placebo controlled trial of bupropion for smoking cessation in schizophrenia. Biological Psychiatry, 52, 53–61.
George, T. P., Ziedonis, D. M., Feingold, A. et al. (2000). Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia. American Journal of Psychiatry, 157, 1835–42.
Germer, C. K., (2005). Anxiety disorders: befriending fear. In C. K. Germer, R. D. Siegel & P. R. Fulton (eds.), Mindfulness and Psychotherapy. New York: Guilford Press, pp. 152–72.
Ghaemi, S. N., Ko, J. Y. & Goodwin, F. K. (2002). ‘Cade's disease’ and beyond: misdiagnosis, antidepressant use, and a proposed definition for bipolar spectrum disorder.Canadian Journal of Psychiatry, 47, 125–34.
Gibbons, J. S., Horn, S. H., Powell, J. M. & Gibbons, J. L. (1984). Schizophrenic patients and their families: a survey in a psychiatric service based on a DGH unit. British Journal of Psychiatry, 144, 70–7.
Giedd, J. N. (2004). Structural magnetic resonance imaging of the adolescent brain. Annals of the New York Academy of Science, 1021, 77–85.
Gilbert, P. L., Harris, M. J., McAdams, L. & Jeste, D. V. (1995). Neuroleptic withdrawal in schizophrenic patients: a review of the literature. Archives of General Psychiatry, 52, 173–88.
Gilmer, W. S., Trivedi, M. H., Rush, A. J. et al. (2005). Factors associated with chronic depressive episodes: a preliminary report from the STAR-D project. Acta Psychiatrica Scandinavica, 112, 425–33.
Gitlin, M. J. (2001). Treatment-resistant bipolar disorder. Bulletin of the Menninger Clinic, 65, 26–40.
Gitlin, M., Nuechterlein, K., Subotnik, K. L. et al. (2001). Clinical outcome following neuroleptic discontinuation in patients with remitted recent-onset schizophrenia. American Journal of Psychiatry, 158, 1835–42.
Glahn, D. C., Thompson, P. M. & Blangero, J. (2007). Neuroimaging endophenotypes: strategies for finding genes influencing brain structure and function. Human Brain Mapping, 28, 488–501.
Glatt, S. J., Faraone, S. V. & Tsuang, M. T. (2003). Association between a functional catechol O-methyltransferase gene polymorphism and schizophrenia: meta-analysis of case-control and family-based studies. American Journal of Psychiatry, 160, 469–76.
Gleeson, J, Jackson, H. J., Stavely, H. & Burnett, P. (1999). Family intervention in early psychosis. In P. D. McGorry & H. J. Jackson (eds.), The Recognition and Management of Early Psychosis. Cambridge, UK: Cambridge University Press, pp. 376–406.
Gleeson, J. F. (2004). The first psychotic relapse: understanding the risks and the opportunities for prevention. In J. F. Gleeson & P. McGorry (eds.), Psychological Interventions in Early Psychosis: A Treatment Handbook. Chichester, UK: John Wiley, pp. 157–74.
Gleeson, J. F. (2005). Preventing EPISODE II: relapse prevention in first-episode psychosis. Australasian Psychiatry, 13, 384–7.
Gleeson, J. F., Jackson, H. J., Stavely, H. & Burnett, P. (1999). Family intervention in early psychosis. In P. D. McGorry & H. J. Jackson (eds.), The Recognition and Management of Early Psychosis: A Preventive Approach. New York: Cambridge University Press, pp. 376–406.
Gleeson, J. F., Rawlings, D., Jackson, H. J. & McGorry, P. D. (2005). Agreeableness and neuroticism as predictors of relapse after first-episode psychosis: a prospective follow-up study. Journal of Nervous and Mental Disease, 193, 160–9.
Gleeson, J. F., Rawlings, D., Jackson, H. J. & McGorry, P. D. (2005a). Early warning signs of relapse following a first episode of psychosis. Schizophrenia Research, 180, 107–11.
Gleeson, J. F., Rawlings, D., Jackson, H. J. & McGorry, P. D. (2005b). Agreeableness and neuroticism as predictors of relapse after first-episode psychosis: a prospective follow-up study. Journal of Nervous and Mental Disease, 193, 160–9.
Gleeson, J. F., Wade, D., Castle, D. et al. (2008a). The Episode II trial of cognitive and family therapy for relapse prevention in early psychosis: rationale and sample characteristics. Journal of Mental Health, 17, 19–32.
Gleeson, J., Jackson, H. J., Stavely, H. & Burnett, P. (1999). Family intervention in early psychosis. In P. D. McGorry & H. J. Jackson (eds.), Recognition and Management of Early Psychosis: A Preventive Approach New York: Cambridge University Press, pp. 376–406.
Gleeson, J., Jackson, H. J., Stavely, H. & Burnett, P. (1999). Family intervention in early psychosis. In P. D. McGorry & H. J. Jackson (eds.), The Recognition and Management of Early Psychosis: A Preventive Approach. New York: Cambridge University Press, pp. 376–406.
Glesson, J. F., Cotton, S., Alvarez-Jimenez, M. et al. (2008b). An RCT of relapse prevention therapy for first-episode psychosis patients. Journal of Clinical Psychiatry, in press.
Godress, J., Ozgul, S., Owen, C. & Foley-Evans, L. (2004). Grief experiences of parents whose children suffer from mental illness. Australian and New Zealand Journal of Psychiatry, 39, 88–94.
Gold, J. M., Goldberg, R. W., McNary, S. W., Dixon, L. B. & Lehman, A. F. (2002). Cognitive correlates of job tenure among patients with severe mental illness. American Journal of Psychiatry, 159, 1395–402.
Goldberg, D. P. & Blackwell, P. (1988). A User's Guide to the General Health Questionnaire. Windsor, UK: NFER-Nelson.
Goldberg, J. F. & Ernst, C. L. (2002). Features associated with the delayed initiation of mood stabilizers at illness onset in bipolar disorder. Journal of Clinical Psychiatry, 63, 985–91.
Goldberg, J. F., Garno, J. L. & Harrow, M. (2005). Long-term remission and recovery in bipolar disorder: a review. Current Psychiatry Reports, 7, 456–61.
Goldberg, T. E., Egan, M. F., Gscheidle, T. et al. (2003). Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia. Archives of General Psychiatry, 60, 889–96.
Goldberg, T. E., Torrey, E. F., Gold, J. M. et al. (1995). Genetic risk of neuropsychological impairment in schizophrenia: a study of monozygotic twins discordant and concordant for the disorder. Schizophrenia Research, 17, 77–84.
Goldman-Rakic, P. S. (1994). Working memory in schizophrenia. Journal of Neuropsychiatry and Clinical Neurosciences, 6, 348–57.
Goldstein, M. J., Rodnick, E. H., Evans, J. R., May, P. R. & Steinberg, M. R. (1978). Drug and family therapy in the aftercare of acute schizophrenics. Archives of General Psychiatry, 35, 1169–77.
Goldston, D. (2000). Assessment of Suicidal Behaviours and Risk Among Children and Adolescents. [Technical Report submitted to NIMH under Contract No 263-MD-909995. Bethesda, MB: National Institutes of Mental Health.
Gonzalez-Pinto, A., Gonzalez, C., Enjuto, S. et al. (2004). Psychoeducation and cognitive-behavioral therapy in bipolar disorder: an update. Acta Psychiatrica Scandinavica, 109, 83–90.
Goodwin, D. R., Amador, F. X., Malaspina, D. et al. (2003). Anxiety and substance use comorbidity among inpatients with schizophrenia. Schizophrenia Research, 61, 89–95.
Goodwin, F. K. & Jamison, K. R. (1990). Manic–Depressive Illness. New York: Oxford University Press.
Goodwin, G. M. for the Consensus Group of the British Association of Psychopharmacology (2003). Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology, 17, 149–73.
Gornick, M. C., Addington, A. M., Sporn, A. et al. (2005). Dysbindin (DTNBP1, 6p22.3) is associated with childhood-onset psychosis and endophenotypes measured by the Premorbid Adjustment Scale (PAS). Journal of Autism and Developmental Disorders, 35, 831–8.
Gottesman, I. I. & Bertelsen, A. (1989). Confirming unexpressed genotypes for schizophrenia. Risks in the offspring of Fischer's Danish identical and fraternal discordant twins. [See comments.] Archives of General Psychiatry, 46, 867–72.
Gottesman, I. I. & Gould, T. D. (2003). The endophenotype concept in psychiatry: etymology and strategic intentions. American Journal of Psychiatry, 160, 1–10.
Gottesman, I. I. & Gould, T. D. (2003). The endophenotype concept in psychiatry: etymology and strategic intentions. American Journal of Psychiatry, 160, 636–45.
Gottesman, I. I. & Shields, J. (1967). A polygenic theory of schizophrenia. Proceedings of the National Academy of Sciences USA, 58, 199–205.
Gottesman, I. I. &, Shields, J. (1976). A critical review of recent adoption, twin, and family studies of schizophrenia: behavioral genetics perspectives. Schizophrenia Bulletin, 2, 360–401.
Graf von Reventlow, H., Ruhrmann, S., Klosterkötter, J. et al. (2004). Comparison of inclusion criteria for an early detection of psychosis study across different countries: first results from the European Prediction of Psychosis Study, EPOS. Schizophrenia Research, 67(Suppl 1), 37.
Graham, H. L., Copello, A., Birchwood, M. J. et al. (2004). Cognitive-behavioural Integrated Treatment (C-BIT): A Treatment Manual for Substance Misuse in People with Severe Mental Health Problems. Chichester, UK: John Wiley.
Grant, C., Addington, J., Addington, D. & Konnert, C. (2001). Social functioning in first- and multi-episode schizophrenia. Canadian Journal of Psychiatry, 46, 746–9.
Gray, R., Wykes, T. & Gournay, K. (2002). From compliance to concordance: a review of the literature on interventions to enhance compliance with antipsychotic medication. Journal of Psychiatry and Mental Health Nursing, 9, 277–84.
Green, A. I., Tohen, M. F., Hamer, R. M. et al. for the HGDH Research Group (2004). First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidol. Schizophrenia Research, 66, 125–35.
Green, B., Kavanagh, D. & Young, R. M. (2004). Reasons for cannabis use in men with and without psychosis. Drug and Alcohol Review, 23, 445–53.
Green, E. K., Raybould, R., MacGregor, S. et al. (2005). Operation of the schizophrenia susceptibility gene, neuregulin 1, across traditional diagnostic boundaries to increase risk for bipolar disorder. Archives of General Psychiatry, 62, 642–8.
Green, G. & Gask, L. (2005). The development, research and implementation of STORM (Skills-based Training on Risk Management). Primary Care Mental Health, 3, 207–13.
Green, L. W. & Kreuter, M. W. (1999). Health Promotion Planning: An Educational and Ecological Approach, 3rd edn. Mountain View, CA: Mayfield.
Green, M. F. (1996). What are the functional consequences of neurocognitive deficits in schizophrenia? American Journal of Psychiatry, 153, 321–30.
Green, M. F., Kern, R. S, Braff, D. L. & Mintz J. (2000). Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the ‘right stuff’? Schizophrenia Bulletin, 26, 119–36.
Green, M. F., Kern, R. S. & Heaton, R. K. (2004). Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS. Schizophrenia Research, 72, 41–51.
Green, M., Nuechterlein, K., Ventura, J. & Mintz, J. (1990). The temporal relationship between depressive and psychotic symptoms in recent-onset schizophrenia. American Journal of Psychiatry, 147, 179–82.
Gross, G. (1989). The ‘basic’ symptoms of schizophrenia. British Journal of Psychiatry, 155(Suppl 7), s21–5.
Gumley, A. & Schwannauer, M. (2006). Staying Well After Psychosis: A Cognitive Interpersonal Approach to Recovery and Relapse Prevention. Chichester, UK: John Wiley.
Gumley, A., O'Grady, M., McNay, L. et al. (2003). Early intervention for relapse in schizophrenia: results of a 12-month randomized controlled trial of cognitive behavioural therapy. Psychological Medicine, 33, 419–31.
Gumley, A., O'Grady, M., Power, K. & Schwannauer, M. (2004). Negative beliefs about self and illness: a comparison of individuals with psychosis with and without comorbid social anxiety disorder. Australian and New Zealand Journal of Psychiatry, 38, 960–4.
Gundez-Bruce, H., McMeniman, M., Robinson, D. G. et al. (2005). Duration of untreated psychosis and time to treatment response for delusions and hallucinations. American Journal of Psychiatry, 162, 1966–9.
Gunduz-Bruce, H., McMeniman, M., Robinson, D. G. et al. (2005). Duration of untreated psychosis and time to treatment response for delusions and hallucinations. American Journal of Psychiatry, 162, 1966–9.
Gupta, R. D. & Guest, J. F. (2002). Annual cost of bipolar disorder to UK society. British Journal of Psychiatry, 180, 227–33.
Gupta, S., Andreasen, N. C., Arndt, S. et al. (1997). The Iowa longitudinal study of recent onset psychosis: one-year follow-up of first episode patients. Schizophrenia Research, 23, 1–13.
Gupta, S., Andreasen, N. C., Arndt, S. et al. (1997). The Iowa Longitudinal Study of Recent Onset Psychosis: one-year follow-up of first episode patients. Schizophrenia Research, 23, 1–13.
Gur, R. E., Calkins, M. E., Gur, R. C. et al. (2007b). The consortium on the genetics of schizophrenia: neurocognitive endophenotypes. Schizophrenia Bulletin, 33, 49–68.
Gur, R. E., Cowell, P., Turetsky, B. I. et al. (1998). A follow-up magnetic resonance imaging study of schizophrenia. Relationship of neuroanatomical changes to clinical and neurobehavioral measures. Archives of General Psychiatry, 55, 145–52.
Gur, R. E., Keshavan, M. S. & Lawrie, S. M. (2007a). Deconstructing psychosis with human brain imaging. Schizophrenia Bulletin, 33, 921–31.
Gut-Fayand, A., Dervaux, A., Olie, J. et al. (2001). Substance abuse and suicidality in schizophrenia: a common risk factor linked to impulsivity. Psychiatry Research, 102, 65–72.
Guy, W. (1976). ECDEU Assessment Manual for Psychopharmacology, revised. [DHEW Publication No. (ADM) 76–338.] Rockville MD: National Institute of Mental Health.
Häfner, H. (1996). Psychiatric rehabilitation: general issues. European Psychiatry, 11, 39s–50s.
Häfner, H., Loffler, W., Mauer, K., Hambrecht, M. & an der Heiden, W. (1999). Depression, negative symptoms, social stagnation and social decline in the early course of schizophrenia. Acta Psychiatrica Scandinavica, 100, 105–18.
Häfner, H., Loffler, W., Maurer, K., Hambrecht, M. & an der Heiden, W. (1999). Depression, negative symptoms, social stagnation and social decline in the early course of schizophrenia. Acta Psychiatrica Scandinavica, 100, 105–18.
Häfner, H., Loffler, W., Maurer, K., Hambrecht, M. & van der Heiden, W. (1999). Depression, negative symptoms, social stagnation and social decline in the early course of schizophrenia. Acta Psychiatrica Scandinavica, 100, 105–18.
Häfner, H., Mauer, K., Trendler, G. et al. (2005). Schizophrenia and depression: challenging the paradigm of two separate diseases – a controlled study of schizophrenia, depression and healthy controls. Schizophrenia Research, 77, 11–24.
Häfner, H., Maurer, K., Loffler, W. & Riecher-Rossler, A. (1993). The influence of age and sex on the onset and early course of schizophrenia. British Journal of Psychiatry, 162, 80–6.
Häfner, H., Maurer, K., Loffler, W. & Riecher-Rossler, A. (1993). The influence of age and sex on the onset and early course of schizophrenia. British Journal of Psychiatry, 162, 80–6.
Häfner, H., Maurer, K., Ruhrmann, S. et al. (2004). Are early detection and secondary prevention feasible? Facts and visions. European Archives of Psychiatry and Clinical Neuroscience, 254, 117–28.
Häfner, H., Maurer, K., Ruhrmann, S. et al. (2004). Early detection and secondary prevention of psychosis: facts and visions. European Archives of Psychiatry and Clinical Neuroscience, 254, 117–28.
Häfner, H., Maurer, K., Trendler, G. et al. (2005). Schizophrenia and depression: challenging the paradigm of two separate diseases: a controlled study of schizophrenia, depression and healthy controls. Schizophrenia Research, 77, 11–24.
Häfner, H., Maurer, K., Trendler, G., van der Heiden, W. & Schmidt, M. (2005). The early course of schizophrenia and depression. European Archives of Psychiatry and Clinical Neuroscience, 255, 167–73.
Häfner, H., Maurer, W., Löffler, B. et al. (1995b). Onset and early course of schizophrenia. In H. Häfner & W. F. Gattaz. (eds.), Causes of Schizophrenia, vol. III. New York: Springer, pp. 43–66.
Häfner, H., Maurer, W., Loffler, B. et al. (1995). Onset and early course of schizophrenia. In H. Häfner & W. F. Gattaz (eds.), Search for the Causes of Schizophrenia. New York: Springer, pp. 43–66.
Häfner, H., Nowotny, B., Löffler, W., van der Heiden, W. & Maurer, K. (1995a). When and how does schizophrenia produce social deficits? European Archives of Psychiatry and Clinical Neuroscience, 246, 17–28.
Häfner, H., Riecher, R. A., Hambrecht, M. et al. (1992). IRAOS: an instrument for the assessment of onset and early course of schizophrenia. Schizophrenia Research, 6, 209–23.
Häfner, H., Riecher-Rossler, A., Hambrecht, M. et al. (1992). IRAOS: an instrument for the assessment of onset and early course of schizophrenia. Schizophrenia Research, 6, 209–23.
Haas, G. & Sweeney, J. A. (1992). Premorbid and onset features of first-episode schizophrenia. Schizophrenia Bulletin, 18, 373–86.
Haddock, G., Barrowclough, C., Tarrier, N. et al. (2003). Cognitive-behavioural therapy and motivational intervention for schizophrenia and substance misuse: 18-month outcomes of a randomised controlled trial. British Journal of Psychiatry, 183, 418–26.
Haghighat, R. (2001). A unitary theory of stigmatization: pursuit of self-interest and routes to destigmatization. British Journal of Psychiatry, 178, 207–15.
Hahlweg, K., Goldstein, M. J., Nuechterlein, K. H. et al. (1989). Expressed emotion and patient–relative interaction in families of recent onset schizophrenics. Journal of Consulting and Clinical Psychology, 57, 11–18.
Hakak, Y., Walker, J. R., Li, C. et al. (2001). Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proceedings of the National Academy of Sciences USA, 98, 4746–51.
Haley, C. J., Drake, R. J., Bentall, R. P. & Lewis, S. W. (2003). Health beliefs link to duration of untreated psychosis and attitudes to later treatment in early psychosis. Social Psychiatry and Psychiatric Epidemiology, 38, 311–16.
Haley, J. (1980). Leaving Home: The Therapy of Disturbed Young People. New York: McGraw-Hill.
Hall, D., Dhilla, A., Charalambous, A., Gogos, J. A. & Karayiorgou, M. (2003). Sequence variants of the brain-derived neurotrophic factor (BDNF) gene are strongly associated with obsessive-compulsive disorder. American Journal of Human Genetics, 73, 370–6.
Hall, J., Whalley, H. C., Job, D. E. et al. (2006). A neuregulin 1 variant associated with abnormal cortical function and psychotic symptoms. Nature Neurosciences, 9, 1477–8.
Hall, P. L. & Tarrier, N. (2003). The cognitive–behavioural treatment of low self-esteem in psychotic patients: a pilot study. Behaviour Research and Therapy, 41, 317–32.
Hamann, J., Cohen, R., Leucht, S., Busch, R. & Kissling W. (2005). Do patients with schizophrenia wish to be involved in decisions about their medical treatment? American Journal of Psychiatry, 162, 2382–4.
Hamann, J., Leucht, S. & Kissling W. (2003). Shared decision making in psychiatry. Acta Psychiatrica Scandinavica, 107, 403–9.
Hambrecht, M. & Häfner, H. (1996). Substance abuse and the onset of schizophrenia. Biological Psychiatry, 40, 1155–63.
Hambrecht, M. & Häfner, H. (1998). Are symptoms observed differently in male and female first-episode patients? Schizophrenia Research, 29, 186.
Hambrecht, M. (1995). A second case of schizophrenia in the family: is it observed differently? European Archives of Psychiatry and Clinical Neuroscience, 245, 267–9.
Hamer, D. (2002). Genetics. Rethinking behavior genetics. Science, 298, 71–2.
Hamera, E., Schneider, J. K. & Deviney, S. (1995). Alcohol, cannabis, nicotine, and caffeine use and symptom distress in schizophrenia. Journal of Nervous and Mental Disease, 183, 559–65.
Handoko, H. Y., Nyholt, D. R., Hayward, N. K. et al. (2005). Separate and interacting effects within the catechol-O-methyltransferase (COMT) are associated with schizophrenia. Molecular Psychiatry, 10, 589–97.
Hansen, L. & Kingdom, D. (2006). Akathisia as a risk factor for suicide. British Journal of Psychiatry, 188, 192.
Hanssen, M., Krabbendam, L., Vollema, M., Delespaul, P. & van Os, J. (2006). Evidence for instrument and family-specific variation of subclinical psychosis dimensions in the general population. Journal of Abnormal Psychology, 115, 5–14.
Hardy, A., Fowler, D., Freeman, D. et al. (2005). Trauma and hallucinatory experience in psychosis. Journal of Nervous and Mental Disease, 193, 501–7.
Harkavy-Friedman, J. M. (2006). Can early detection of psychosis prevent suicidal behaviour? American Journal of Psychiatry, 163, 768–70.
Harkavy-Friedman, J. M., Restifo, K., Malaspina, D. et al. (1999). Suicidal behaviour in schizophrenia: characteristics of individuals who had and had not attempted suicide. American Journal of Psychiatry, 156, 1276–8.
Haroun, N., Dunn, L., Haroun, A. & Cadenhead, K. (2006). Risk and protection in prodromal schizophrenia: ethical implications for clinical practice and future research. Schizophrenia Bulletin, 32, 166–78.
Haroun, N., Dunn, L., Haroun, A. & Cadenhead, K. S. (2006). Risk and protection in prodromal schizophrenia: ethical implications for clinical practice and future research. Schizophrenia Bulletin, 32, 166–78.
Harrigan, S. M., McGorry, P. D. & Krstev, H. (2003). Does treatment delay in first-episode psychosis really matter? Psychological Medicine, 33, 97–110.
Harrigan, S. M., McGorry, P. D. & Krstev, H. (2003). Does treatment delay in first-episode psychosis really matter? Psychological Medicine, 33, 97–110.
Harrigan, S. M., McGorry, P. D. & Krstev, H. (2003). Does treatment delay in first-episode psychosis really matter? Psychological Medicine, 33, 97–110.
Harrigan, S. M., McGorry, P. D. & Krstev, H. (2003). Does treatment delay in first-episode psychosis really matter? Psychological Medicine, 33, 97–110.
Harrington, R., Fudge, H., Rutter, M., Pickles, A. & Hill, J. (1990) Adult outcomes of childhood and adolescent depression: I. Psychiatric status. Archives of General Psychiatry, 47, 465–73.
Harris, J. M., Moorhead, T. W., Miller, P. et al. (2007). Increased prefrontal gyrification in a large high-risk cohort characterizes those who develop schizophrenia and reflects abnormal prefrontal development. Biological Psychiatry, 62, 722–9.
Harris, J. M., Yates, S., Miller, P. et al. (2004). Gyrification in first-episode schizophrenia: a morphometric study. Biological Psychiatry, 55, 141–7.
Harris, M. G., Henry, L. P., Harrigan, S. M. et al. (2005). The relationship between duration of untreated psychosis and outcome: an eight-year prospective study. Schizophrenia Research, 79, 85–93.
Harris, M. G., Henry, L. P., Harrigan, S. M. et al. (2005). The relationship between duration of untreated psychosis and outcome: an eight-year prospective study. Schizophrenia Research, 79, 85–93.
Harris, M., Edwards, J., Ratnaike, D. et al. (2004). Evaluating treatment integrity in early psychosis programs: comparing what is promised with what is delivered. In T. Ehman, G. W. MacEwan & W. G. Honer (eds.), Best Care in Early Psychosis: Global Perspectives. London: Taylor & Francis, pp. 167–74.
Harrison, B. J., Yücel, M., Shaw, M. et al. (2006). Dysfunction of dorsolateral prefrontal cortex in antipsychotic-naive schizophreniform psychosis. Psychiatry Research, 148, 23–31.
Harrison, G., Croudace, T., Mason, P., Glazebrook, C. & Medley, I. (1996). Predicting the long-term outcome of schizophrenia. Psychological Medicine, 26, 697–705.
Harrison, G., Glazebrook, C., Brewin, J. et al. (1997). Increased incidence of psychotic disorders in migrants from the Caribbean to the United Kingdom. Psychological Medicine, 27, 799–806.
Harrison, G., Hopper, K., Craig, T. et al. (2001). Recovery from psychotic illness: a 15 and 25 year international follow-up study. British Journal of Psychiatry, 178, 506–17.
Harrison, G., Hopper, K., Craig, T. et al. (2001). Recovery from psychotic illness: a 15- and 25-year international follow-up study. British Journal of Psychiatry, 178, 506–17.
Harrison, G., Hopper, K., Craig, T., et al. (2001). Recovery from psychotic illness: a 15-and 25-year international follow-up study. British Journal of Psychiatry, 178, 506–17.
Harrison, P. J. & Law, A. J. (2006). Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology. Biological Psychiatry, 60, 132–40.
Harrison, P. J. & Lewis, D. A. (2003). Neuropathology of schizophrenia. In S. R. Hirsch & D. R. Weinberger (eds.), Schizophrenia. Oxford: Blackwell Science, pp. 310–25.
Harrison, P. J. & Weinberger, D. R. (2005). Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Molecular Psychiatry, 10, 40–68.
Harrison, P. J. & Weinberger, D. R. (2005). Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Molecular Psychiatry, 10, 40–68.
Harrison, P. J. & Weinberger, D. R. (2005). Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Molecular Psychiatry, 10, 40–68; image 5.
Harrow, M., Goldberg, J. F., Grossman, L. S. & Meltzer, H. Y. (1990). Outcome in manic disorders. Archives of General Psychiatry, 47, 665–71.
Harvey, K., Burns, T., Fahy, T., Manley, C. & Tattan, T. (2001b). Relatives of patients with severe psychotic illness: factors that influence appraisal of caregiving and psychological distress. Social Psychiatry and Psychiatric Epidemiology, 36, 456–61.
Harvey, K., Burns, T., Sedgwick, P. et al. (2001a). Relatives of patients with severe psychotic disorders: factors that influence contact frequency. British Journal of Psychiatry, 178, 248–54.
Harvey, P. D., Meltzer, H., Simpson, G. M. et al. (2004). Improvement in cognitive function following a switch to ziprasidone from conventional antipsychotics, olanzapine, or risperidone in outpatients with schizophrenia, Schizophrenia Research, 66, 101–13.
Harvey, S. B., Dean, K., Morgan, C. et al. (2006). How often does deliberate self-harm precipitate first presentation to services with psychosis? Findings from the AESOP Study, Schizophrenia Research, 86, S56–7.
Hashimoto, R., Straub, R. E., Weickert, C. S. et al. (2004). Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia. Molecular Psychiatry, 9, 299–307.
Hawi, Z., Straub, R. E., O'Neill, A. et al. (1998). No linkage or linkage disequilibrium between brain-derived neurotrophic factor (BDNF) dinucleotide repeat polymorphism and schizophrenia in Irish families. Psychiatry Research, 81, 111–16.
Hawkins, K. A., Addington, J., Keefe, R. S. E. et al. (2004). Neuropsychological status of subjects at high risk for a first episode of psychosis. Schizophrenia Research, 67, 115–22.
Hawkins, K. A., McGlashan, T. H., Quinlan, D. et al. (2004). Factorial structure of the Scale of Prodromal Symptoms. Schizophrenia Research, 68, 339–47.
Hawton, K., Sutton, L., Haw, C., Sinclair, J. & Deeks, J. (2005a). Schizophrenia and suicide: systematic review of risk factors. British Journal of Psychiatry, 187, 9–20.
Hawton, K., Sutton, L., Haw, C., Sinclair, J. & Deeks, J. J. (2005). Schizophrenia and suicide: systematic review of risk factors. British Journal of Psychiatry, 187, 9–20.
Hawton, K., Sutton, L., Haw, C., Sinclair, J. & Harris, L. (2005b). Suicide and attempted suicide in bipolar disorder: a systematic review of risk factors. Journal of Clinical Psychiatry, 66, 693–704.
Heckers, S. (2001). Neuroimaging studies of the hippocampus in schizophrenia. Hippocampus, 11, 520–8.
Heikkilä, J., Karlsson, H., Taiminen, T. et al. (2002). Expressed emotion is not associated with disorder severity in first-episode mental disorder. Psychiatry Research, 111, 155–65.
Heikkila, J., Karlsson, H., Taiminen, T. et al. (2002). Expressed emotion is not associated with disorder severity in first-episode mental disorder. Psychiatry Research, 111, 155–65.
Heilä, H. & Lönnqvist, J. (2003). The clinical epidemiology of suicide in schizophrenia. In R. M. Murray, P. B. Jones, E. Susser, J. Van Os & M. Cannon (eds.), The Epidemiology of Schizophrenia. Cambridge, UK: Cambridge University Press, pp. 288–316.
Heilä, H. (1999). Suicide in schizophrenia: a review. Psychiatria Fennica, 30, 47–57.
Heinrichs, R. W. & Zakzanis, K. K. (1998). Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology, 12, 426–45.
Heinrichs, R. W. (2005). The primacy of cognition in schizophrenia. American Psychologist, 60, 229–42.
Heinssen, R. K., Perkins, D. O., Appelbaum, P. S. & Fenton, W. S. (2001). Informed consent in early psychosis research: National Institute of Mental Health Workshop, November 15, 2000. Schizophrenia Bulletin, 27, 571–84.
Helgason, L. (1990). Twenty years follow-up of first psychiatric presentation for schizophrenia: what could have been prevented? Acta Psychiatrica Scandinavica, 81, 231–5.
Hennah, W., Tuulio-Henriksson, A., Paunio, T. et al. (2005). A haplotype within the DISC1 gene is associated with visual memory functions in families with a high density of schizophrenia. Molecular Psychiatry, 10, 1097–103.
Hennah, W., Varilo, T., Kestila, M. et al. (2003). Haplotype transmission analysis provides evidence of association for DISC1 to schizophrenia and suggests sex-dependent effects. Human Molecular Genetics, 12, 3151–9.
Hennion, J. P., el-Masri, M. A., Huff, M. O. & el-Mailakh, R. S. (2002). Evaluation of neuroprotection by lithium and valproic acid against ouabain-induced cell damage. Bipolar Disorders, 4, 201–6.
Henquet, C., Krabbendam, L., Spauwen, J. et al. (2005). Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. British Medical Journal, 330, 11–14.
Henquet, C., Murray, R., Linszen, D. & van Os, J. (2005). The environment and schizophrenia: the role of cannabis use. Schizophrenia Bulletin, 31, 608–12.
Henquet, C., Rosa, A., Krabbendam, L. et al. (2006). An experimental study of catechol-O-methyltransferase Val158Met moderation of delta-9-tetrahydrocannabinol-induced effects on psychosis and cognition. Neuropsychopharmacology, 31, 2748–57.
Henry, A. D., Barreira, S. B., Brown, J-M. & McKay, C. (2001). A retrospective study of clubhouse-based transitional employment. Psychiatric Rehabilitation Journal, 24, 344–54.
Henry, L. (2004). Psychological intervention in recovery from early psychosis: cognitively oriented psychotherapy. In J. Gleeson & P. D. McGorry, (eds.), Psychological Interventions in Early Psychosis: A Treatment Handbook. Chichester, UK: John Wiley, pp. 63–80.
Hercus, M., Lubman, D. I. & Hellard, M. (2005). Blood borne viral and sexually transmissible infections among psychiatric populations: what are we doing about them? Australian and New Zealand Journal of Psychiatry, 39, 849–55.
Heresco-Levy, U., Greenberg, D. & Dasberg, H. (1990). Family expressed emotion: concepts, dilemmas and the Israeli perspective. Israel Journal of Psychiatry and Related Sciences, 27, 205–15.
Herken, H. & Erdal, M. E. (2001). Catechol-O-methyltransferase gene polymorphism in schizophrenia: evidence for association between symptomatology and prognosis. Psychiatric Genetics, 11, 105–9.
Hermann-Doig, T., Maude, D. & Edwards, J. (2003). Systematic Treatment of Persisting Psychosis (STOPP): A Guide for Facilitating Recovery From First Episode Psychosis. London: Martin Dunitz.
Herz, M. I., Lamberti, J. S., Mintz, J. et al. (2000). A program for relapse prevention in schizophrenia: a controlled study. Archives of General Psychiatry, 57, 277–83.
Hides, L., Dawe, S., Kavanagh, D. J. & Young, R. M. (2006). Psychotic symptom and cannabis relapse in recent-onset psychosis: a prospective study. British Journal of Psychiatry, 189, 137–43.
Hides, L., Lubman, D. & Dawe, S. (2004). Models of co-occurring substance misuse and psychosis: are personality traits the missing link? Drug and Alcohol Review, 23, 425–32.
Hinrichsen, G. A. & Pollack, S. (1997). Expressed emotion and the course of late-life depression. Journal of Abnormal Psychology, 106, 336–40.
Hinton, M., Elkins, K., Edwards, J. & Donovan, K. (2002). Cannabis and Psychosis: An Early Psychosis Treatment Manual. Melbourne: Early Psychosis Prevention and Intervention Centre.
Hirayasu, Y., Asato, N., Ohta, H. et al. (1998). Abnormalities of auditory event-related potentials in schizophrenia prior to treatment. Biological Psychiatry, 43, 244–53.
Hirayasu, Y., Tanaka, S., Shenton, M. E. et al. (2001). Prefrontal gray matter volume reduction in first episode schizophrenia. Cerebral Cortex, 11, 374–81.
Hiroeh, U., Appleby, L., Mortensen, P. & Dunn, G. (2001). Death by homicide, suicide, and other unnatural causes in people with mental illness: a population-based study. Lancet, 358, 2110–12.
Hirsch, S., Bowen, J., Emmani, J. et al. (1996). A one year prospective study of the effects of life events and medication in the aetiology of schizophrenic relapse. British Journal of Psychiatry, 168, 49–56.
Hirschfeld, R. M., Calabrese, J. R., Weissman, M. M. et al. (2003a). Screening for bipolar disorder in the community. Journal of Clinical Psychiatry, 64, 53–9.
Hirschfeld, R. M., Lewis, L. & Vornik, L. A. (2003b). Perceptions and impact of bipolar disorder: how far have we really come? Results of the National Depressive and Manic Depressive Association 2000 Survey of Individuals with Bipolar Disorder. Journal of Clinical Psychiatry, 64, 161–74.
Ho, B-C. & Andreasen, N. C. (2001). Long delays in seeking treatment for schizophrenia. Lancet, 157, 898–900.
Ho, B-C., Andreasen, N. & Flaum, M. (1997). Dependence on public financial support early in the course of schizophrenia. Psychiatric Services, 48, 948–50.
Ho, B. & Andreasen, N. C. (2001). Long delays in seeking treatment for schizophrenia. Lancet, 357, 898–9.
Ho, B. C., Alicata, D., Ward, J. et al. (2003). Untreated initial psychosis: relation to cognitive deficits and brain morphology in first-episode schizophrenia. American Journal of Psychiatry, 160, 142–8.
Ho, B. C., Nopoulos, P., Flaum, M., Arndt, S. & Andreasen, N. C. (1998). Two-year outcome in first-episode schizophrenia: predictive value of symptoms for quality of life. American Journal of Psychiatry, 155, 1196–201.
Ho, B., Andreasen, N. C., Flaum, M., Nopoulos, P. & Miller, D. (2000). Untreated initial psychosis: its relation to quality of life and symptom remission in first-episode schizophrenia. American Journal of Psychiatry, 157, 808–15.
Hoch, P. & Polatin, P. (1949). Pseudoneurotic forms of schizophrenia. Psychiatric Quarterly, 23, 248–76.
Hodgkinson, C. A., Goldman, D., Jaeger, J. et al. (2004). Disrupted in schizophrenia 1 (DISC1): association with schizophrenia, schizoaffective disorder, and bipolar disorder. American Journal of Human Genetics, 75, 862–72.
Hofer, A., Hummer, M., Kemmler, G. et al. (2003). The safety of clozapine in the treatment of first- and multiple-episode patients with treatment-resistant schizophrenia. International Journal of Neuropsychopharmacology, 6, 201–6.
Hoff, A. L., Svetina, C., Shields, G., Stewart, J. & DeLisi, L. E. (2005). Ten year longitudinal study of neuropsychological functioning subsequent to a first episode of schizophrenia. Schizophrenia Research, 78, 27–34.
Hofstra, M., Ende, J. & Verhulst, F. (2001). Adolescents' self-reported problems as predictors of psychopathology in adulthood: 10-year follow-up study. British Journal of Psychiatry, 179, 203–9.
Hogg, B., Jackson, H. J., Rudd, R. P. & Edwards, J. (1990). Diagnosing personality disorders in recent-onset schizophrenia. Journal of Nervous and Mental Disease, 178, 194–9.
Holliday, E. G., Handoko, H. Y., James, M. R. et al. (2006). Association study of the dystrobrevin-binding gene with schizophrenia in Australian and Indian samples. Twin Research and Human Genetics, 9, 531–9.
Hollis, C. (2003). Developmental precursors of child and adolescent-onset schizophrenia and affective psychoses: diagnostic specificity and continuity with symptom dimensions. British Journal of Psychiatry, 182, 37–44.
Holthausen, E. A. E., Wiersma, D., Cahn W. et al. (2007). Predictive value of cognition for different domains of outcome in recent-onset schizophrenia. Psychiatry Research, 149, 71–80.
Hong, C. J., Yu, Y. W., Lin, C. H. & Tsai, S. J. (2003). An association study of a brain-derived neurotrophic factor Val66Met polymorphism and clozapine response of schizophrenic patients. Neuroscience Letters, 349, 206–8.
Hooley, J. M. & Hiller, J. B. (1998). Expressed emotion and the pathogenesis of relapse in schizophrenia. In M. F. Lenzenweger & R. H. Dworkin (eds.), Origins and Development of Schizophrenia: Advances in Experimental Psychopathology. Washington, DC: American Psychological Press, pp. 447–68.
Hooley, J. M. (1986). Expressed emotion and depression: interactions between patients and high- versus low-expressed-emotion spouses. Journal of Abnormal Psychology, 95, 237–46.
Horan, W. P., Subotnik, K. L., Reise, S. P., Ventura, J. & Nuechterlein, K. H. (2005). Stability and clinical correlates of personality characteristics in recent-onset schizophrenia. Psychological Medicine, 35, 995–1005.
Horan, W. P., Subotnik, K. L., Reise, S. P., Ventura, J. & Nuechterlein, K. H. (2005). Stability and clinical correlates of personality characteristics in recent-onset schizophrenia. Psychological Medicine, 35, 995–1005.
House, A., Bostock, J. & Cooper, J. (1987). Depressive symptoms in the year following onset of a first schizophrenic illness. British Journal of Psychiatry, 151, 773–9.
Hovatta, I., Lichtermann, D., Juvonen, H. et al. (1998). Linkage analysis of putative schizophrenia gene candidate regions on chromosomes 3p, 5q, 6p, 8p, 20p and 22q in a population-based sampled Finnish family set. Molecular Psychiatry, 3, 452–7.
Hubain, P. P., Simonnet, M. P. & Mendlewicz, J. (1986). The dexamethasone suppression test in affective illnesses and schizophrenia: relationship with psychotic symptoms. Neuropsychobiology, 16, 57–60.
Huber, G. & Gross, G. (1989). The concept of basic symptoms in schizophrenic and schizoaffective psychoses. Recent Progress in Medicine, 80, 646–52.
Huber, G., Gross, G. & Schuttler, R. (1975). A long-term follow-up study of schizophrenia: psychiatric course of illness and prognosis. Acta Psychiatrica Scandinavica, 52, 49–57.
Huguelet, P., Favre, S., Binyet, S., Gonzalez, C. & Zabala, I. (1995). The use of the Expressed Emotion Index as a predictor of outcome in first admitted schizophrenic patients in a French speaking area of Switzerland. Acta Psychiatrica Scandinavica, 92, 447–52.
Huguelet, P., Favre, S., Binyet, S., Gonzalez, C. & Zabala, I. (1995). The use of the Expressed Emotion Index as a predictor of outcome in first admitted schizophrenic patients in a French speaking area of Switzerland. Acta Psychiatrica Scandinavica, 92, 447–52.
Hulshoff Pol, H. E., Schnack, H. G., Mandl, R. C. et al. (2006). Gray and white matter density changes in monozygotic and same-sex dizygotic twins discordant for schizophrenia using voxel-based morphometry. Neuroimage, 31, 482–8.
Hunt, G. E., Bergen, J. & Bashir, M. (2002). Medication compliance and comorbid substance abuse in schizophrenia: impact on community survival four years after a relapse. Schizophrenia Research, 54, 253–64.
Hunt, I. M., Kapur, N., Windfuhr, K. et al. (2006). Suicide in schizophrenia: findings from a national clinical survey. Journal of Psychiatric Practice, 12, 139–47.
Huq, Z. U. For the RIS-GBR-32 Investigators (2004). A trial of low doses of risperidone in the treatment of patients with first-episode schizophrenia, schizophreniform disorder, or schizoaffective disorder. Journal of Clinical Psychopharmacology, 24, 220–4.
Hutchinson, G., Takei, N., Fahy, T. A. et al. (1996). Morbid risk of schizophrenia in first-degree relatives of white and African-Caribbean patients with psychosis. British Journal of Psychiatry, 169, 776–80.
Huttenlocher, P. (1984). Synapse elimination and plasticity in developing human cerebral cortex. American Journal of Mental Deficiency, 88, 488–96.
Huxley, N. A., Parikh, S. V. & Baldessarini, R. J. (2000). Effectiveness of psychosocial treatments in bipolar disorder: state of the evidence. Harvard Review of Psychiatry, 8, 126–40.
Iles, U. G. (1928). Farm work for mental cases. US Veterans Bureau Medical Bulletin, 4, 282–5.
Ingraham, L. J., Kugelmass, S., Frenkel, E., Nathan, M. & Mirsky, A. F. (1995). Twenty-five-year followup of the Israeli High-Risk Study: current and lifetime psychopathology. Schizophrenia Bulletin, 21, 183–92.
Insel, T. R. & Fenton, W. S. (2005). Psychiatric epidemiology: it's not just about counting anymore. Archives of General Psychiatry, 62, 590–2.
Inskip, H., Harris, E. C. & Barraclough, B. (1998). Lifetime risk of suicide for affective disorder, alcoholism and schizophrenia. British Journal of Psychiatry, 172, 35–7.
International Early Psychosis Association Writing Group (2005). International clinical practice guidelines for early psychosis. British Journal of Psychiatry, 187(Suppl 48), s120–4.
International Early Psychosis Association Writing Group (2005). International clinical practice guidelines for early psychosis. British Journal of Psychiatry, 187(Suppl 48), s120–4.
International Early Psychosis Association Writing Group (2005). International clinical practice guidelines for early psychosis. British Journal of Psychiatry, 187(Suppl 48), s120–4.
International Early Psychosis Association Writing Group (2005). International clinical practice guidelines for early psychosis.British Journal of Psychiatry, 187(Suppl. 48), 120–4.